{"content":"<li class=\"n-box-item date-title\" data-end=\"1561607999\" data-start=\"1561521600\" data-txt=\"Monday, December 23, 2019\">Wednesday, June 26, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3474148\" data-ts=\"1561607395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBIO\" target=\"_blank\">BBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474148-bridgebio-pharma-prices-ipo-17-above-high-end-of-range\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BridgeBio Pharma prices its IPO at $17, above the high end of the range</a></h4><ul> <li>BridgeBio Pharma (<a href='https://seekingalpha.com/symbol/BBIO' title='BridgeBio Pharma'>BBIO</a>) has priced its initial public offering of 20.5M common shares at $17.</li><li>Underwriters over-allotment is an additional 3.075M  common stock.</li><li>The shares are expected to begin trading on the Nasdaq on June 27 under the ticker symbol \"BBIO\"</li><li>Closing date is July 1.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17557219-bridgebio-pharma-announces-pricing-initial-public-offering\" target=\"_blank\">Press Release</a></li><li>Prior: <a href=\"https://seekingalpha.com/news/3473808-bridgebio-files-upsized-ipo\" target=\"_blank\">BridgeBio files for upsized IPO</a></li><li><strong>Update</strong>: Shares opened at $30.61.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474148\" data-linked=\"BridgeBio Pharma prices its IPO at $17, above the high end of the range\" data-tweet=\"$BBIO - BridgeBio Pharma prices its IPO at $17, above the high end of the range https://seekingalpha.com/news/3474148-bridgebio-pharma-prices-ipo-17-above-high-end-of-range?source=tweet\" data-url=\"https://seekingalpha.com/news/3474148-bridgebio-pharma-prices-ipo-17-above-high-end-of-range\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474142\" data-ts=\"1561588815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZYXI\" target=\"_blank\">ZYXI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474142-zynexminus-7_1-on-shareholder-offering-from-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zynex -7.1% on shareholder offering from CEO</a></h4><ul>   <li>Zynex (NASDAQ:<a href='https://seekingalpha.com/symbol/ZYXI' title='Zynex, Inc.'>ZYXI</a>) is <font color=\"red\">off 7.1%</font> postmarket after shareholders <a href=\"https://seekingalpha.com/filing/4545613\" target=\"_blank\">filed to offer 16,661,571 common shares</a>.</li>    <li>The selling shareholders are CEO Thomas Sandgaard, holder of a 52% equity ownership, and Sandgaard Holdings (44.8%).</li>    <li>The company won't receive any proceeds from any sale.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474142\" data-linked=\"Zynex -7.1% on shareholder offering from CEO\" data-tweet=\"$ZYXI - Zynex -7.1% on shareholder offering from CEO https://seekingalpha.com/news/3474142-zynexminus-7_1-on-shareholder-offering-from-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/3474142-zynexminus-7_1-on-shareholder-offering-from-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474132\" data-ts=\"1561584985\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAD\" target=\"_blank\">RAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474132-rite-aid-routed-after-q1-loss-doubles-vs-year-ago\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rite Aid routed after Q1 loss more than doubles vs. year ago</a></h4><ul><li>Rite Aid (NYSE:<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a>) <font color=\"red\">-10.7%</font> after-hours following a widening <a href=\"https://seekingalpha.com/news/3474082-rite-aid-eps-beats-0_79-revenue-line\" target=\"_blank\">Q1 loss</a> from continuing operations totaling $1B, or $1.88/share vs. a $0.79 net loss in the prior-year quarter, and adjusted EBITDA fell to $110.3M from $138M in the year-ago quarter.</li><li>Q1 revenues came in flat at $5.4B, and retail pharmacy segment same store sales increased 1.4%.</li><li>RAD says Q1 results failed to meet expectations \"due to prescription reimbursement rate pressure in the retail pharmacy segment and margin compression in the pharmacy services segment.\"</li><li>RAD reiterates its FY 2020 outlook for sales of $21.5B-$21.9B vs. $21.6B analyst consensus, with same store sales expected to come in flat to 1% higher vs. 2019; it also expects adjusted EBITDA of $500M-$560M and adjusted net loss income between a $0.14/share loss and $0.72 income.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474132\" data-linked=\"Rite Aid routed after Q1 loss more than doubles vs. year ago\" data-tweet=\"$RAD - Rite Aid routed after Q1 loss more than doubles vs. year ago https://seekingalpha.com/news/3474132-rite-aid-routed-after-q1-loss-doubles-vs-year-ago?source=tweet\" data-url=\"https://seekingalpha.com/news/3474132-rite-aid-routed-after-q1-loss-doubles-vs-year-ago\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>98&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474131\" data-ts=\"1561584866\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474131-ofg-vrca-acrs-and-pir-among-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OFG, VRCA, ACRS and PIR among after hour movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/OFG' title='OFG Bancorp'>OFG</a> <font color=\"green\">+20.1%</font>. <a href='https://seekingalpha.com/symbol/PUMSY' title='PUMA SE'>OTCPK:PUMSY</a> <font color=\"green\">+19.1%</font>. <a href='https://seekingalpha.com/symbol/VRCA' title='Verrica Pharmaceuticals Inc.'>VRCA</a> <font color=\"green\">+13.1%</font>. <a href='https://seekingalpha.com/symbol/MLHR' title='Herman Miller, Inc.'>MLHR</a> <font color=\"green\">+11.7%</font>. <a href='https://seekingalpha.com/symbol/DODXF' title='DEUT BK LKD DOW JONES'>OTCPK:DODXF</a> <font color=\"green\">+8.6%</font>.</li><li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/ACRS' title='Aclaris Therapeutics, Inc.'>ACRS</a> <font color=\"red\">-32.6%</font>. <a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports, Inc.'>PIR</a> <font color=\"red\">-18.9%</font>. <a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a> <font color=\"red\">-10.7%</font>. <a href='https://seekingalpha.com/symbol/FUL' title='H.B. Fuller Company'>FUL</a> <font color=\"red\">-6.5%</font>. <a href='https://seekingalpha.com/symbol/MSGN' title='MSG Networks Inc.'>MSGN</a> <font color=\"red\">-5.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474131\" data-linked=\"OFG, VRCA, ACRS and PIR among after hour movers\" data-tweet=\"$OFG $PUMSY $VRCA - OFG, VRCA, ACRS and PIR among after hour movers https://seekingalpha.com/news/3474131-ofg-vrca-acrs-and-pir-among-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474131-ofg-vrca-acrs-and-pir-among-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474111\" data-ts=\"1561582275\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474111-nvidia-gains-bull\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nvidia gains a bull</a></h4><ul><li>In its wave of <a href=\"https://seekingalpha.com/news/3474102-wedbush-bearish-intel\" target=\"_blank\">semiconductor starts</a>, Wedbush initiates Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) at Outperform with a PT of $184, a 16% upside.</li><li>Nvidia shares are <font color=\"green\">up 0.6%</font> after hours to $159.56.</li><li>NVDA has an Outperform <a href=\"https://seekingalpha.com/symbol/NVDA/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474111\" data-linked=\"Nvidia gains a bull\" data-tweet=\"$NVDA - Nvidia gains a bull https://seekingalpha.com/news/3474111-nvidia-gains-bull?source=tweet\" data-url=\"https://seekingalpha.com/news/3474111-nvidia-gains-bull\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474108\" data-ts=\"1561581921\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474108-higher-costs-ding-national-beverage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Higher costs ding National Beverage</a></h4><ul> <li>National Beverage (NASDAQ:<a href='https://seekingalpha.com/symbol/FIZZ' title='National Beverage Corp.'>FIZZ</a>) reports net income fell to $141M for the fiscal year ending on April 27 from $150M a year ago.</li> <li>The company says net income was impacted by increased aluminum costs primarily due to tariffs, increased manufacturing costs, higher shipping and marketing spending  and a $4.3M one-time reduction of FY 2018 income tax expense resulting from the 2017 Tax Cuts and Jobs Act.</li> <li>Shares are <font color=\"red\">down 1.59%</font> in AH trading to $41.55.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3474106-national-beverage-eps-misses-0_11-revenue-line\" target=\"_blank\">National Beverage EPS misses by $0.11,  revenue in-line</a> (June 26)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474108\" data-linked=\"Higher costs ding National Beverage\" data-tweet=\"$FIZZ - Higher costs ding National Beverage https://seekingalpha.com/news/3474108-higher-costs-ding-national-beverage?source=tweet\" data-url=\"https://seekingalpha.com/news/3474108-higher-costs-ding-national-beverage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474104\" data-ts=\"1561581556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRCA\" target=\"_blank\">VRCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474104-verricas-vpminus-102-shows-positive-effect-in-mid-stage-study-shares-up-6-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Verrica&#39;s VP-102 shows positive effect in mid-stage study; shares up 6% after hours</a></h4><ul><li>Verrica Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/VRCA' title='Verrica Pharmaceuticals Inc.'>VRCA</a>) <a href=\"https://seekingalpha.com/pr/17556965-verrica-pharmaceuticals-achieves-positive-topline-results-phase-2-clinical-study-vpminus-102\" target=\"_blank\">announces</a> positive results from an open-label Phase 2 clinical trial, COVE-1, evaluating VP-102 for the treatment of verruca vulgaris (common warts).</li><li>51% (n=18/35) of patients in Cohort 2 treated with VP-102, a 0.7% solution of cantharidin, showed complete clearance of all warts at day 84.</li><li>On the safety front, VP-102 was well-tolerated with no serious adverse events observed.</li><li>The company plans to request an end-of-Phase 2 meeting with the FDA to clarify a registration path. It plans to file a U.S. marketing application later this year for molluscum contagiosum.</li><li>Management will host a conference call tomorrow, June 27, at 8:00 am ET to discuss the results.</li><li>Shares are up <font color=\"green\">6%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474104\" data-linked=\"Verrica&#39;s VP-102 shows positive effect in mid-stage study; shares up 6% after hours\" data-tweet=\"$VRCA - Verrica&#39;s VP-102 shows positive effect in mid-stage study; shares up 6% after hours https://seekingalpha.com/news/3474104-verricas-vpminus-102-shows-positive-effect-in-mid-stage-study-shares-up-6-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3474104-verricas-vpminus-102-shows-positive-effect-in-mid-stage-study-shares-up-6-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474102\" data-ts=\"1561581380\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474102-wedbush-out-bearish-on-intel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wedbush out bearish on Intel</a></h4><ul><li>Wedbush starts Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) at Underperform with a $37.50 price target, a 22% downside. The firm <a href=\"https://seekingalpha.com/news/3474095-wedbush-starts-amd-bull\" target=\"_blank\">started</a> rival AMD at Outperform.</li><li>Intel shares are <font color=\"red\">down 0.9%</font> after hours to $47.78.</li><li>INTC has a Hold <a href=\"https://seekingalpha.com/symbol/INTC/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li><li>Update with more details from the note:</li><li>Analyst Matthew Bryson thinks INTC's recent road map execution struggles and cyclical downturns in its key markets \"create an uncertain future with downside risk to estimates.\"</li><li>In the near-term, Bryson says Intel faces headwinds from the U.S. ban on Huawei and general macro concerns.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474102\" data-linked=\"Wedbush out bearish on Intel\" data-tweet=\"$INTC - Wedbush out bearish on Intel https://seekingalpha.com/news/3474102-wedbush-out-bearish-on-intel?source=tweet\" data-url=\"https://seekingalpha.com/news/3474102-wedbush-out-bearish-on-intel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474101\" data-ts=\"1561581354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBH\" target=\"_blank\">KBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474101-kb-homeplus-4_2-fiscal-q2-eps-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KB Home +4.2% as fiscal Q2 EPS beats</a></h4><ul><li>KB Home (NYSE:<a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a>) <font color=\"green\">jumps 4.2%</font> in after-hours trading after <a href=\"https://seekingalpha.com/pr/17556997-kb-home-reports-2019-second-quarter-results\" target=\"_blank\">fiscal Q2 EPS </a>of 51 cents beat the average analyst estimate of 38 cents.</li><li>Net order value for the quarter ended May 31, 2019 rose 13% Y/Y to $1.53B, driven by double-digit order growth in each of its four regions.</li><li>\"We are confident we can produce further improvement in our results in the second half of this year,\" said Chairman, President, and CEO Jeffrey Mezger.</li><li>Q2 total revenue of $1.02B, exceeding the consensus estimate of $933.5M, declined from $1.10B a year ago.</li><li>Average selling price in the quarter fell 8% Y/Y to $367,700, mainly due to a shift in geographic mix of homes delivered and a changing mix of communities in its West Coast region.</li><li>Cancellation rate as a percentage of gross orders improved to 15% from 18%.</li><li>Ending backlog value decreased to $2.17B from $2.24B.</li><li>Average community count increased 17% to 252.</li><li><a href=\"https://investor.kbhome.com/events/event-details/kb-homes-2019-second-quarter-earnings-conference-call\" target=\"_blank\">Conference call </a>at 5:00 PM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3474081-kb-home-eps-beats-0_13-beats-revenue\" target=\"_blank\">KB Home EPS beats by $0.13, beats on revenue</a> (June 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3474101\" data-linked=\"KB Home +4.2% as fiscal Q2 EPS beats\" data-tweet=\"$KBH - KB Home +4.2% as fiscal Q2 EPS beats https://seekingalpha.com/news/3474101-kb-homeplus-4_2-fiscal-q2-eps-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3474101-kb-homeplus-4_2-fiscal-q2-eps-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474093\" data-ts=\"1561580839\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACRS\" target=\"_blank\">ACRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474093-aclaris-atiminus-502-flunks-mid-stage-alopecia-areata-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aclaris&#39; ATI-502 flunks mid-stage alopecia areata study</a></h4><ul><li>Aclaris Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ACRS' title='Aclaris Therapeutics, Inc.'>ACRS</a>) is set for a significant down move on the heels of a <a href=\"https://seekingalpha.com/pr/17556969-aclaris-therapeutics-announces-phase-2-clinical-trial-atiminus-502-topical-patients-alopecia\" target=\"_blank\">failed Phase 2 clinical trial </a>evaluating ATI-502 in patients with an autoimmune disorder characterized by hair loss called alopecia areata.</li><li>The study did not meet the primary or secondary endpoints due to high rates of disease resolution in the vehicle (placebo) arm.</li><li>Management will host a conference call at 5:00 pm ET to discuss the results.</li><li>Shares will resume trading at 4:30 pm ET.</li><li><strong>Update</strong>: Shares are down <font color=\"red\">33%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474093\" data-linked=\"Aclaris&#39; ATI-502 flunks mid-stage alopecia areata study\" data-tweet=\"$ACRS - Aclaris&#39; ATI-502 flunks mid-stage alopecia areata study https://seekingalpha.com/news/3474093-aclaris-atiminus-502-flunks-mid-stage-alopecia-areata-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3474093-aclaris-atiminus-502-flunks-mid-stage-alopecia-areata-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474088\" data-ts=\"1561580422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PIR\" target=\"_blank\">PIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474088-pier-1-imports-eps-misses-8_47-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pier 1 Imports EPS misses by $8.47, misses on revenue</a></h4><ul><li>Pier 1 Imports (NYSE:<a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports, Inc.'>PIR</a>): Q1 GAAP EPS of -$19.97 <font color=\"red\">misses by $8.47</font>.</li><li>Revenue of $314.3M (-15.5% Y/Y) <font color=\"red\">misses by $30.9M</font>.</li><li>Shares <font color=\"green\">+3.6%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17557017-pier-1-imports-inc-reports-first-quarter-fiscal-2020-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3474088\" data-linked=\"Pier 1 Imports EPS misses by $8.47, misses on revenue\" data-tweet=\"$PIR - Pier 1 Imports EPS misses by $8.47, misses on revenue https://seekingalpha.com/news/3474088-pier-1-imports-eps-misses-8_47-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3474088-pier-1-imports-eps-misses-8_47-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474086\" data-ts=\"1561580412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOTS\" target=\"_blank\">MOTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474086-motus-gi-readies-equity-offering-shares-down-9-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Motus GI readies equity offering; shares down 9% after hours</a></h4><ul><li>Motus GI Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MOTS' title='Motus GI Holdings, Inc.'>MOTS</a>) is down <font color=\"red\">9%</font> after hours in reaction to its planned <a href=\"https://seekingalpha.com/pr/17556963-motus-gi-announces-proposed-public-offering-common-stock\" target=\"_blank\">stock offering</a>. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474086\" data-linked=\"Motus GI readies equity offering; shares down 9% after hours\" data-tweet=\"$MOTS - Motus GI readies equity offering; shares down 9% after hours https://seekingalpha.com/news/3474086-motus-gi-readies-equity-offering-shares-down-9-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3474086-motus-gi-readies-equity-offering-shares-down-9-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474081\" data-ts=\"1561580024\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBH\" target=\"_blank\">KBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474081-kb-home-eps-beats-0_13-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KB Home EPS beats by $0.13, beats on revenue</a></h4><ul><li>KB Home (NYSE:<a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a>): Q2 GAAP EPS of $0.51 <font color=\"green\">beats by $0.13</font>.</li><li>Revenue of $1.02B (-6.4% Y/Y) <font color=\"green\">beats by $86.51M</font>.</li><li>Shares <font color=\"green\">+5%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17556997-kb-home-reports-2019-second-quarter-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3474081\" data-linked=\"KB Home EPS beats by $0.13, beats on revenue\" data-tweet=\"$KBH - KB Home EPS beats by $0.13, beats on revenue https://seekingalpha.com/news/3474081-kb-home-eps-beats-0_13-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3474081-kb-home-eps-beats-0_13-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474071\" data-ts=\"1561579842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYGN\" target=\"_blank\">MYGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474071-myriad-genetics-runs-to-close-up-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Myriad Genetics runs to close, up 17%</a></h4><ul><li>Myriad Genetics (<a href='https://seekingalpha.com/symbol/MYGN' title='Myriad Genetics, Inc.'>MYGN</a> <font color=\"green\">+17.2%</font>) galloped to the close on more than double normal volume. This morning, it <a href=\"https://seekingalpha.com/pr/17554157-myriad-announces-publication-first-comprehensive-economic-study-demonstrating-cost\" target=\"_blank\">announced</a> the publication of results from an analysis by a Canadian investigator that showed the cost-effectiveness of its EndoPredict breast cancer test compared to Genomic Health's (<a href='https://seekingalpha.com/symbol/GHDX' title='Genomic Health, Inc.'>GHDX</a> <font color=\"red\">-0.3%</font>) Oncotype DX.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474071\" data-linked=\"Myriad Genetics runs to close, up 17%\" data-tweet=\"$MYGN $GHDX - Myriad Genetics runs to close, up 17% https://seekingalpha.com/news/3474071-myriad-genetics-runs-to-close-up-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3474071-myriad-genetics-runs-to-close-up-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474078\" data-ts=\"1561579662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLHR\" target=\"_blank\">MLHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474078-herman-miller-eps-beats-0_10-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Herman Miller EPS beats by $0.10, beats on revenue</a></h4><ul><li>Herman Miller (NASDAQ:<a href='https://seekingalpha.com/symbol/MLHR' title='Herman Miller, Inc.'>MLHR</a>): Q4 Non-GAAP EPS of $0.88 <font color=\"green\">beats by $0.10</font>; GAAP EPS of $0.78 in-line.</li><li>Revenue of $671M (+8.6% Y/Y) <font color=\"green\">beats by $13.77M</font>.</li><li>Shares <font color=\"green\">+3.73%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17556984-herman-miller-reports-fourth-quarter-fiscal-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3474078\" data-linked=\"Herman Miller EPS beats by $0.10, beats on revenue\" data-tweet=\"$MLHR - Herman Miller EPS beats by $0.10, beats on revenue https://seekingalpha.com/news/3474078-herman-miller-eps-beats-0_10-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3474078-herman-miller-eps-beats-0_10-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474074\" data-ts=\"1561579504\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474074-faa-identifies-new-potential-risk-on-boeing-737-max-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FAA identifies new potential risk on Boeing 737 MAX - Reuters</a></h4><ul><li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color=\"green\">+1.6%</font>) pared gains into the close following a Reuters report that the Federal Aviation Administration has found a \"<a href=\"https://www.reuters.com/article/us-ethiopia-airplane-faa-boeing-exclusiv/exclusive-faa-says-identifies-new-potential-risk-on-737-max-idUSKCN1TR30J\" target=\"_blank\">potential risk</a>\" that the company must fix before the 737 MAX can return to service.</li><li>The risk was discovered during a simulator test last week, which likely will prevent BA from running a certification test flight until at least July 8, according to the report.</li><li><strong>Update:</strong> BA <a href=\"https://www.sec.gov/Archives/edgar/data/12927/000001292719000049/a201906jun268k.htm\" target=\"_blank\">discloses</a> the FAA has asked it to address a specific condition of flight not covered by planned software changes; the company says it is  working on the required software to address the FAA's request.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474074\" data-linked=\"FAA identifies new potential risk on Boeing 737 MAX - Reuters\" data-tweet=\"$BA - FAA identifies new potential risk on Boeing 737 MAX - Reuters https://seekingalpha.com/news/3474074-faa-identifies-new-potential-risk-on-boeing-737-max-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3474074-faa-identifies-new-potential-risk-on-boeing-737-max-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>150&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474070\" data-ts=\"1561579038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGLN\" target=\"_blank\">MGLN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474070-magellan-health-in-sale-talks-shares-up-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Magellan Health in sale talks; shares up 9%</a></h4><ul><li>The WSJ <a href=\"https://www.wsj.com/articles/centerbridge-in-exclusive-talks-to-buy-magellan-health-11561578626\" target=\"_blank\">reports</a> that private equity shop Centerbridge Partners LP is in exclusive negotiations with Magellan Health (<a href='https://seekingalpha.com/symbol/MGLN' title='Magellan Health, Inc.'>MGLN</a> <font color=\"green\">+8.5%</font>) about a possible sale. Informed sources say a deal could be reached next month.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474070\" data-linked=\"Magellan Health in sale talks; shares up 9%\" data-tweet=\"$MGLN - Magellan Health in sale talks; shares up 9% https://seekingalpha.com/news/3474070-magellan-health-in-sale-talks-shares-up-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3474070-magellan-health-in-sale-talks-shares-up-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474066\" data-ts=\"1561578715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGO\" target=\"_blank\">EGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474066-eldorado-gold-upgraded-j-p-morgan-following-gold-break-out\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eldorado Gold upgraded at J.P. Morgan following gold &#39;break out&#39;</a></h4><ul><li>Eldorado Gold (<a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a> <font color='green'>+5%</font>) outgains most of its peers today after J.P. Morgan <a href=\"https://thefly.com/thestreet/realmoney/index.php/EGOid2926554/EGO-Eldorado-Gold-upgraded-to-Neutral-following-gold-break-out-at-JPMorgan\" target=\"_blank\">upgrades</a> shares to Neutral from Underweight, as analyst John Bridges says the yellow metal's \"break out\" in price has \"put a different complexion\" on the company.</li><li>Gold's gain, \"while not opening the floodgates of new funds for miners,\" has at least reminded investors about the sector, Bridges says, also noting the more pro-business New Democracy party has been leading in Greek polling all year ahead of elections in July.</li><li>Bridges has a $6 price target on the U.S.-listed EGO stock and a C$8 target on the Canadian-listed shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474066\" data-linked=\"Eldorado Gold upgraded at J.P. Morgan following gold &#39;break out&#39;\" data-tweet=\"$EGO - Eldorado Gold upgraded at J.P. Morgan following gold &#39;break out&#39; https://seekingalpha.com/news/3474066-eldorado-gold-upgraded-j-p-morgan-following-gold-break-out?source=tweet\" data-url=\"https://seekingalpha.com/news/3474066-eldorado-gold-upgraded-j-p-morgan-following-gold-break-out\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474065\" data-ts=\"1561578633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FAF\" target=\"_blank\">FAF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474065-title-insurers-texas-rate-cut-effect-should-be-minimal-kbw-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Title insurers&#39; Texas rate cut effect should be minimal, KBW says</a></h4><ul><li>First American Financial (<a href='https://seekingalpha.com/symbol/FAF' title='First American Financial Corporation'>FAF</a> <font color='red'>-3.6%</font>) sees Texas title rates cut by 4.9% starting in September, according to a note from KBW analysts led by Bose George.</li><li>KBW estimates the move could reduce total premiums by about 75 basis points; increased escrow fees may help offset the reduction, FAF said.</li><li>\"We do not expect the earnings impact of this fee reduction in Texas to be meaningful for title insurance company earnings,\" the analysts wrote.</li><li>Fidelity National Financial (NYSE:<a href='https://seekingalpha.com/symbol/FNF' title='Fidelity National Financial, Inc.'>FNF</a>) <font color=\"red\">fell 3.1%</font> and Old Republic International (NYSE:<a href='https://seekingalpha.com/symbol/ORI' title='Old Republic International Corporation'>ORI</a>), which has a title insurance group, fell <font color=\"red\">2.4%</font> in late trading.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474065\" data-linked=\"Title insurers&#39; Texas rate cut effect should be minimal, KBW says\" data-tweet=\"$FAF $FNF $ORI - Title insurers&#39; Texas rate cut effect should be minimal, KBW says https://seekingalpha.com/news/3474065-title-insurers-texas-rate-cut-effect-should-be-minimal-kbw-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3474065-title-insurers-texas-rate-cut-effect-should-be-minimal-kbw-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474062\" data-ts=\"1561577760\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QEP\" target=\"_blank\">QEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474062-qep-resources-in-advanced-deal-talks-elliott-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">QEP Resources in advanced deal talks with Elliott - Bloomberg</a></h4><ul><li>QEP Resources (<a href='https://seekingalpha.com/symbol/QEP' title='QEP Resources, Inc.'>QEP</a> <font color=\"green\">+15.2%</font>) spikes after Bloomberg reports Elliott Management is <a href=\"https://www.streetinsider.com/Hot+M+and+A/Elliott+Said+to+be+in+Advanced+Talks+to+Buy+QEP+Resources+%28QEP%29+-+Bloomberg/15649565.html\" target=\"_blank\">in advanced talks to buy the company</a>, and that Elliott previously made an offer to acquire QEP in January; the news triggered a circuit breaker halt about a half-hour ago.</li><li>Bloomberg reported <a href=\"https://seekingalpha.com/news/3465430-sale-chatter-propels-qep-resources-bloomberg\" target=\"_blank\">last month</a> that QEP had attracted interest from Blackstone as well as drillers Whiting Petroleum and Callon Petroleum.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474062\" data-linked=\"QEP Resources in advanced deal talks with Elliott - Bloomberg\" data-tweet=\"$QEP - QEP Resources in advanced deal talks with Elliott - Bloomberg https://seekingalpha.com/news/3474062-qep-resources-in-advanced-deal-talks-elliott-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3474062-qep-resources-in-advanced-deal-talks-elliott-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474060\" data-ts=\"1561577439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPHI\" target=\"_blank\">IPHI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474060-bofaml-says-buy-to-inphi\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofAML says Buy to Inphi</a></h4><ul><li>Inphi (NYSE:<a href='https://seekingalpha.com/symbol/IPHI' title='Inphi Corporation'>IPHI</a>) <font color=\"green\">gains 1.8%</font> to $49.38 with the general semi rally and the BofAML upgrade earlier today.</li><li>The firm moved IPHI from Underperform to Buy and raised the target from $32 to $60, a 32% upside from the last close.</li><li>IPHI has an Outperform <a href=\"https://seekingalpha.com/symbol/IPHI/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474060\" data-linked=\"BofAML says Buy to Inphi\" data-tweet=\"$IPHI - BofAML says Buy to Inphi https://seekingalpha.com/news/3474060-bofaml-says-buy-to-inphi?source=tweet\" data-url=\"https://seekingalpha.com/news/3474060-bofaml-says-buy-to-inphi\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474057\" data-ts=\"1561577242\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCOR\" target=\"_blank\">SCOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474057-comscore-slides-again-after-financingminus-9_8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ComScore slides again after financing, -9.8%</a></h4><ul>   <li>Heavy volume is still driving comScore (NASDAQ:<a href='https://seekingalpha.com/symbol/SCOR' title='comScore, Inc.'>SCOR</a>) to further record lows after <a href=\"https://seekingalpha.com/news/3473233-comscore-seals-20m-investment-via-private-placement\" target=\"_blank\">Monday's private placement news</a>, with shares <font color=\"red\">down 9.8%</font> today to $5.50.</li>    <li>The stock finished yesterday <font color=\"red\">18% lower</font>, with Loop Capital expressing <a href=\"https://seekingalpha.com/news/3473775-comscore-taps-record-low-loop-capital-frets-dilution\" target=\"_blank\">concerns about potential dilution</a>.</li>    <li>Volume is about 267% of normal today alongside William Blair adding an opinion: The placement should remove some uncertainty about the need for capital, but \"the cost of the financing is a little disappointing.\" The firm's sticking with a Market Perform considering there are avenues to new growth.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3474057\" data-linked=\"ComScore slides again after financing, -9.8%\" data-tweet=\"$SCOR - ComScore slides again after financing, -9.8% https://seekingalpha.com/news/3474057-comscore-slides-again-after-financingminus-9_8?source=tweet\" data-url=\"https://seekingalpha.com/news/3474057-comscore-slides-again-after-financingminus-9_8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474055\" data-ts=\"1561577092\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFE\" target=\"_blank\">PFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474055-pfizer-in-red-cdc-advisory-committee-reviews-patient-populations-for-prevnar-13\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pfizer in red as CDC advisory committee reviews patient populations for Prevnar 13</a></h4><ul><li>The broad selloff in the healthcare sector notwithstanding, Pfizer (<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color=\"red\">-2.3%</font>) is under additional pressure, albeit modest, in apparent reaction to a two-day meeting at the CDC Atlanta.</li><li>The <a href=\"https://www.cdc.gov/vaccines/acip/index.html\" target=\"_blank\">Advisory Committee on Immunization Practices</a> &#40;ACIP&#41; is discussing immunization practices for a range of vaccines, including HPV, pneumococcus, measles, rabies, pertussis, diptheria and tetanus.</li><li>Investors seem wary that the committee may vote to modify the targeted patient population for the company's pneumococcal vaccine <a href=\"https://www.prevnar13.com/\" target=\"_blank\">PREVNAR 13</a>. The specific population that may be amended appears to be adults over the age of 65.</li><li><strong>Update</strong>: The committee voted to revise the pneumococcal vaccination guidelines for adults aged 65+ based on \"shared clinical decision-making\" between the patients and healthcare provider. In other words, the vaccination decision should be made on an individual basis based on mutual agreement.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474055\" data-linked=\"Pfizer in red as CDC advisory committee reviews patient populations for Prevnar 13\" data-tweet=\"$PFE - Pfizer in red as CDC advisory committee reviews patient populations for Prevnar 13 https://seekingalpha.com/news/3474055-pfizer-in-red-cdc-advisory-committee-reviews-patient-populations-for-prevnar-13?source=tweet\" data-url=\"https://seekingalpha.com/news/3474055-pfizer-in-red-cdc-advisory-committee-reviews-patient-populations-for-prevnar-13\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474054\" data-ts=\"1561576892\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WORK\" target=\"_blank\">WORK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474054-slackplus-7-new-bull-sees-achievable-targets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Slack +7% as new bull sees &#39;achievable&#39; targets</a></h4><ul><li>More details from yesterday's <a href=\"https://seekingalpha.com/news/3473730-baird-gives-slack-bull-start\" target=\"_blank\">Baird initiation</a> of Slack (NYSE:<a href='https://seekingalpha.com/symbol/WORK' title='Slack Technologies, Inc.'>WORK</a>) with an Outperform rating and a $44 PT, which still has shares in motion.</li><li>Analyst William Power:\"With penetration early, we are positive on the strong growth and competitive position. Valuation is rich relative to the group, though we believe the disruptive competitive position and long-term margin and free-cash-flow opportunity stand out relative to the group.\u201d</li><li>Power thinks Slack's long-term targets of 20-30% operating margins and 30% FCF margins as achievable since the company already has strong margins and an attractive growth profile.</li><li>WORK shares are <font color=\"green\">up 7%</font> to $37.45.</li><li>Slack has an Outperform <a href=\"https://seekingalpha.com/symbol/WORK/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474054\" data-linked=\"Slack +7% as new bull sees &#39;achievable&#39; targets\" data-tweet=\"$WORK - Slack +7% as new bull sees &#39;achievable&#39; targets https://seekingalpha.com/news/3474054-slackplus-7-new-bull-sees-achievable-targets?source=tweet\" data-url=\"https://seekingalpha.com/news/3474054-slackplus-7-new-bull-sees-achievable-targets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474053\" data-ts=\"1561576874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBH\" target=\"_blank\">SBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474053-sally-beauty-continues-digital-transformation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sally Beauty continues digital transformation</a></h4><ul> <li>Sally Beauty Holdings (<a href='https://seekingalpha.com/symbol/SBH' title='Sally Beauty Holdings, Inc.'>SBH</a> <font color='green'>+1.5%</font>) trades higher after announcing the launch of a new app for iOS and Android devices.</li><li>The retailer says the app roll-out is a continuation of the brand's digital transformation plan.</li><li>Shares of SBH were jolted earlier this week when Amazon announced the launch of a pro beauty store.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17556893-sally-beauty-launches-new-mobile-app-support-15-million-loyalty-members\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3474053\" data-linked=\"Sally Beauty continues digital transformation\" data-tweet=\"$SBH - Sally Beauty continues digital transformation https://seekingalpha.com/news/3474053-sally-beauty-continues-digital-transformation?source=tweet\" data-url=\"https://seekingalpha.com/news/3474053-sally-beauty-continues-digital-transformation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474051\" data-ts=\"1561576577\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474051-technology-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers</a></h4><ul><li><b>Gainers:</b> Aerohive Networks (NYSE:<a href='https://seekingalpha.com/symbol/HIVE' title='Aerohive Networks, Inc.'>HIVE</a>) <font color=\"green\">+39%</font>. BroadVision (NASDAQ:<a href='https://seekingalpha.com/symbol/BVSN' title='BroadVision, Inc.'>BVSN</a>) <font color=\"green\">+19%</font>. Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) <font color=\"green\">+18%</font>. Powerbridge Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/PBTS' title='Powerbridge Technologies Co., Ltd.'>PBTS</a>) <font color=\"green\">+15%</font>. Net Element (NASDAQ:<a href='https://seekingalpha.com/symbol/NETE' title='Net Element, Inc.'>NETE</a>) <font color=\"green\">+14%</font>.</li><li><b>Losers:</b> Care.com (NYSE:<a href='https://seekingalpha.com/symbol/CRCM' title='Care.com, Inc.'>CRCM</a>) <font color=\"red\">-21%</font>. Pareteum (NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) <font color=\"red\">-18%</font>. Moxian (NASDAQ:<a href='https://seekingalpha.com/symbol/MOXC' title='Moxian, Inc.'>MOXC</a>) <font color=\"red\">-11%</font>. Qudian (NYSE:<a href='https://seekingalpha.com/symbol/QD' title='Qudian Inc.'>QD</a>) <font color=\"red\">-10%</font>. Phunware (NASDAQ:<a href='https://seekingalpha.com/symbol/PHUN' title='Phunware, Inc.'>PHUN</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474051\" data-linked=\"Technology - Top 5 Gainers / Losers\" data-tweet=\"$HIVE $BVSN $RIOT - Technology - Top 5 Gainers / Losers https://seekingalpha.com/news/3474051-technology-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474051-technology-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474049\" data-ts=\"1561575712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474049-pareteumminus-18_7-viceroy-piles-on-short-reporting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum -18.7% as Viceroy piles on short reporting</a></h4><ul>   <li>Pareteum (NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) is <font color=\"red\">18.7% lower</font>, pummeled by its second short call this month.</li>    <li>In a report referring to \"<a href=\"https://viceroyresearch.org/2019/06/26/pareteum-the-wild-west-of-telecoms/\" target=\"_blank\">The Wild West of Telecoms</a>,\" Viceroy Research echoes concerns that a string of promoted customer wins show a \"larger number are insignificant,\" and that \"the companies behind them appear in no way capable of fulfilling the contract values advertised by Pareteum.\"</li>    <li>It adds that the company looks to be in breach of U.S. sanctions against Iran via providing services to Iranian MVNO Admin SMC.</li>    <li>The firm also argues that the 36-month backlog isn't an accurate predictor of future profits, saying that the company should have reported 73% more revenue in Q1 than it did.</li>    <li>Shares <font color=\"red\">lost 24% of value</font> on June 7 after a <a href=\"https://seekingalpha.com/news/3469934-pareteum-minus-31-percent-aurelius-value-posts-short-report\" target=\"_blank\">short call by Aurelius Value</a>. To that, Viceroy says \"Kudos to Aurelius Value for beating us to the punch. We identify further non-existent contracts, undisclosed related parties, and an apparent breach of Iran sanctions.\"</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3474049\" data-linked=\"Pareteum -18.7% as Viceroy piles on short reporting\" data-tweet=\"$TEUM - Pareteum -18.7% as Viceroy piles on short reporting https://seekingalpha.com/news/3474049-pareteumminus-18_7-viceroy-piles-on-short-reporting?source=tweet\" data-url=\"https://seekingalpha.com/news/3474049-pareteumminus-18_7-viceroy-piles-on-short-reporting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474048\" data-ts=\"1561575624\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GO\" target=\"_blank\">GO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474048-grocery-outlet-runs-to-new-post-ipo-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Grocery Outlet runs to new post-IPO high</a></h4><ul><li>Shares of Grocery Outlet Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/GO' title='Grocery Outlet Holding Corp.'>GO</a>) are <font color=\"green\">up 12.6%</font> and reached a new post-IPO high of $35.63 earlier in the session.</li><li>The IPO priced last week at $22 per share.</li><li>Earlier this week, Seeking Alpha contributor BOOX Research <a href=\"https://seekingalpha.com/article/4271775-grocery-outlet-holdings-valuation-disconnect-margin-reality\" target=\"_blank\">warned</a> that GO's valuation has disconnected from the chain's margin reality.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474048\" data-linked=\"Grocery Outlet runs to new post-IPO high\" data-tweet=\"$GO - Grocery Outlet runs to new post-IPO high https://seekingalpha.com/news/3474048-grocery-outlet-runs-to-new-post-ipo-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3474048-grocery-outlet-runs-to-new-post-ipo-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474047\" data-ts=\"1561575205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMB\" target=\"_blank\">WMB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474047-williams-upgraded-kinder-morgan-holly-energy-downgraded-ray-jay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Williams upgraded; Kinder Morgan, Holly Energy downgraded at Ray Jay</a></h4><ul><li>Williams Cos. (<a href='https://seekingalpha.com/symbol/WMB' title='The Williams Companies, Inc.'>WMB</a> <font color=\"green\">+2.9%</font>) is <a href=\"https://www.barrons.com/articles/williams-stock-mast-limited-partnership-sum-of-parts-valuation-kinder-morgan-mlp-oil-energy-51561557768\" target=\"_blank\">upgraded to Strong Buy</a> from Outperform with a $32 price target at Raymond James, where analyst Justin Jenkins says shares are trading at a 20% discount to his sum-of-the-parts value.</li><li>Analyst Justin Jenkins also notes attractive Transco franchise growth, upside to Northeast G&amp;P volumes and cash flow potential from deepwater assets, among other reasons for the upgrade.</li><li>On the flip side, Jenkins downgrades Kinder Morgan (<a href='https://seekingalpha.com/symbol/KMI' title='Kinder Morgan, Inc.'>KMI</a> <font color=\"green\">+0.3%</font>) to Market Perform from Outperform, saying shares are up ~35% YTD and trade at an above-peer multiple despite a mixed outlook for the asset portfolio.</li><li>Jenkins also cuts Holly Energy Partners (<a href='https://seekingalpha.com/symbol/HEP' title='Holly Energy Partners, L.P.'>HEP</a> <font color=\"red\">-0.9%</font>) to Underperform from Market Perform, saying HEP's defensive characteristics such as high minimum volume commitments, predictable cash flow and a supportive sponsor in HollyFrontier (<a href='https://seekingalpha.com/symbol/HFC' title='HollyFrontier Corporation'>HFC</a> <font color=\"green\">+1.7%</font>) should provide a premium valuation, but \"that premium is slightly higher than warranted, especially relative to slower growth and higher than peer leverage.\"</li><li>WMB's average <a href=\"https://seekingalpha.com/symbol/WMB/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Buy, while both its <a href=\"https://seekingalpha.com/symbol/WMB/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> and <a href=\"https://seekingalpha.com/symbol/WMB/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> are Bullish.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474047\" data-linked=\"Williams upgraded; Kinder Morgan, Holly Energy downgraded at Ray Jay\" data-tweet=\"$WMB $KMI $HEP - Williams upgraded; Kinder Morgan, Holly Energy downgraded at Ray Jay https://seekingalpha.com/news/3474047-williams-upgraded-kinder-morgan-holly-energy-downgraded-ray-jay?source=tweet\" data-url=\"https://seekingalpha.com/news/3474047-williams-upgraded-kinder-morgan-holly-energy-downgraded-ray-jay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474046\" data-ts=\"1561574038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAYRY\" target=\"_blank\">BAYRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474046-bayer-seeks-outside-litigation-on-roundup-elliott-reveals-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bayer seeks outside litigation on Roundup; Elliott reveals stake</a></h4><ul><li>Bayer (<a href='https://seekingalpha.com/symbol/BAYRY' title='Bayer Aktiengesellschaft'>OTCPK:BAYRY</a> <font color='green'>+4.3%</font>) says it has hired an external lawyer to advise its supervisory board and formed a new committee in an attempt to resolve the company's multi-billion dollar <a href=\"https://www.nasdaq.com/article/bayer-seeks-outside-advice-on-litigation-as-elliott-reveals-stake-20190626-00754\" target=\"_blank\">glyphosate litigation problem</a>.</li><li>Taking the job is U.S. lawyer John Beisner from Skadden, Arps, Slate Meagher &amp; Flom LLP to advise the supervisory board on matters related to the glyphosate litigations, including trial tactics and mediation.</li><li>More than 13K plaintiffs in the U.S. allege Bayer's glyphosate weedkiller Roundup, produced by Monsanto, caused cancer and that the company failed to warn about risks in using the product.</li><li>Elliott Associates discloses it holds Bayer shares and financial instruments equivalent valued at 1.1B ($1.3B) and says the company's steps today will provide a new level of oversight and a fresh perspective to a litigation strategy, which it says needs a radical overhaul.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474046\" data-linked=\"Bayer seeks outside litigation on Roundup; Elliott reveals stake\" data-tweet=\"$BAYRY - Bayer seeks outside litigation on Roundup; Elliott reveals stake https://seekingalpha.com/news/3474046-bayer-seeks-outside-litigation-on-roundup-elliott-reveals-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3474046-bayer-seeks-outside-litigation-on-roundup-elliott-reveals-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474043\" data-ts=\"1561573674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CJREF\" target=\"_blank\">CJREF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474043-corus-entertainmentminus-6-profits-dip-in-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corus Entertainment -6% as profits dip in Q3</a></h4><ul>   <li>Corus Entertainment (<a href='https://seekingalpha.com/symbol/CJREF' title='Corus Entertainment Inc.'>OTCPK:CJREF</a>) is <font color=\"red\">6% lower</font> in U.S. trading after it missed profit expectations with its <a href=\"https://seekingalpha.com/news/3473790-corus-entertainment-reports-q3-results\" target=\"_blank\">Q3 earnings</a>, where revenues grew but adjusted EPS fell more than 16%.</li>    <li>Revenues rose 4%, boosting year-to-date growth to 3%, with TV advertising revenues up 10%.</li>    <li>Those were offset slightly by \"lower subscriber revenues and softness in our radio segment,\" says CEO Doug Murphy, who notes the company's achieved its leverage target a quarter ahead of schedule.</li>    <li>Year-over-year comparisons were heavily impact by previous broadcast license and goodwill impairment charges of C$1.01B; on an adjusted basis, attributable net income fell to C$66.1M from C$78.1M.</li>    <li>Radio revenues fell nearly 4% to C$36.9M.</li>    <li>Profit by segment: Television, C$166.6 (up 3.6%); Radio, C$9.8M (down 14.7%).</li>    <li><a href=\"https://seekingalpha.com/article/4272242-corus-entertainment-inc-2019-q3-results-earnings-call-slides\" target=\"_blank\">Earnings call slides</a></li>    <li><a href=\"https://seekingalpha.com/pr/17555806-corus-entertainment-announces-fiscal-2019-third-quarter-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3474043\" data-linked=\"Corus Entertainment -6% as profits dip in Q3\" data-tweet=\"$CJREF - Corus Entertainment -6% as profits dip in Q3 https://seekingalpha.com/news/3474043-corus-entertainmentminus-6-profits-dip-in-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3474043-corus-entertainmentminus-6-profits-dip-in-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474042\" data-ts=\"1561573427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOP\" target=\"_blank\">SHOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474042-shopify-adds-apple-business-chat-pay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shopify adds Apple Business Chat, Pay</a></h4><ul><li>Shopify (NYSE:<a href='https://seekingalpha.com/symbol/SHOP' title='Shopify Inc.'>SHOP</a>) <a href=\"https://news.shopify.com/connect-with-your-customers-on-apple-business-chat-through-shopify-ping#\" target=\"_blank\">rolls out</a> Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) Business Chat to 800K+ merchants worldwide.</li><li>The Messages button will appear on every page of an online store to allow visitors to ask questions and pay directly through the chat with Apple Pay.</li><li>Merchants can respond to and manage Messages through Shopify Ping, the mobile app the company announced last year.</li><li>Shopify shares are <font color=\"green\">up 1%</font> to $287.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474042\" data-linked=\"Shopify adds Apple Business Chat, Pay\" data-tweet=\"$SHOP $SHOP $AAPL - Shopify adds Apple Business Chat, Pay https://seekingalpha.com/news/3474042-shopify-adds-apple-business-chat-pay?source=tweet\" data-url=\"https://seekingalpha.com/news/3474042-shopify-adds-apple-business-chat-pay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>372&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474039\" data-ts=\"1561573098\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COP\" target=\"_blank\">COP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474039-conocophillips-raised-to-buy-mizuho-on-improved-unit-cash-margins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ConocoPhillips raised to Buy at Mizuho on improved unit cash margins</a></h4><ul><li>In a day filled with <a href=\"https://seekingalpha.com/news/3473967-oil-surges-biggest-u-s-crude-inventory-drawdown-nearly-three-years\" target=\"_blank\">broad gains</a> for oil and gas shares, ConocoPhillips (<a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color=\"green\">+5.2%</font>) climbs more than most after Mizuho <a href=\"https://thefly.com/thestreet/realmoney/index.php/COPid2926444/COP-ConocoPhillips-upgraded-to-Buy-from-Neutral-at-Mizuho\" target=\"_blank\">upgrades shares to Buy</a> from Neutral with an $80 price target, raised from $74.</li><li>Mizuho analyst Paul Sankey says COP is among the best positioned for the \"new E&amp;P model\" after having taken major steps to improve unit cash margins through divestitures and liquids-led unconventional growth, and is lowering fixed cost burdens by undertaking major debt reduction and share buybacks.</li><li>\"We think the cash return message will begin to evolve and become more dividend-focused,\" Sankey writes.</li><li>COP's average <a href=\"https://seekingalpha.com/symbol/COP/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Outperform, its <a href=\"https://seekingalpha.com/symbol/COP/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> is Neutral, and its <a href=\"https://seekingalpha.com/symbol/COP/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Very Bullish.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474039\" data-linked=\"ConocoPhillips raised to Buy at Mizuho on improved unit cash margins\" data-tweet=\"$COP - ConocoPhillips raised to Buy at Mizuho on improved unit cash margins https://seekingalpha.com/news/3474039-conocophillips-raised-to-buy-mizuho-on-improved-unit-cash-margins?source=tweet\" data-url=\"https://seekingalpha.com/news/3474039-conocophillips-raised-to-buy-mizuho-on-improved-unit-cash-margins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474036\" data-ts=\"1561572590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFPT\" target=\"_blank\">PFPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474036-proofpointplus-4-needham-predicts-robust-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Proofpoint +4% as Needham predicts &#39;robust year&#39;</a></h4><ul><li>Needham reaffirms its Buy rating and $135 price target on Proofpoint (NASDAQ:<a href='https://seekingalpha.com/symbol/PFPT' title='Proofpoint, Inc.'>PFPT</a>) .</li><li>Analyst Alex Henderson says PFPT is \"on track to deliver another robust year,\" and he senses that \"the current quarter is progressing well.\"</li><li>Henderson is optimistic on Proofpoint's growth, billings, margins, strong subscription uptake, and improving sales productivity.</li><li>Proofpoint is expected to report earnings on July 25. Consensus <a href=\"https://seekingalpha.com/symbol/PFPT/earnings\" target=\"_blank\">estimates</a> have revenue of $211.33M with $0.36 EPS.</li><li>Proofpoint shares are <font color=\"green\">up 4.1%</font> to $115.80.</li><li>PFPT has a Buy <a href=\"https://seekingalpha.com/symbol/PFPT/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474036\" data-linked=\"Proofpoint +4% as Needham predicts &#39;robust year&#39;\" data-tweet=\"$PFPT - Proofpoint +4% as Needham predicts &#39;robust year&#39; https://seekingalpha.com/news/3474036-proofpointplus-4-needham-predicts-robust-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3474036-proofpointplus-4-needham-predicts-robust-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474033\" data-ts=\"1561572566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474033-spread-widens-on-abbvie-bonds-after-allergan-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spread widens on AbbVie bonds after Allergan bid</a></h4><ul><li>Yield-sensitive debt investors are, no doubt, looking at AbbVie's (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color=\"green\">+3.2%</font>) outstanding notes after it announced its $63B bid for Allergan yesterday.</li><li>The spread on the company's top traded issue, 4.875% notes due 2048, has widened by more than 20 basis points since yesterday with a current yield of ~4.65%, ~30 basis points higher than the average BB-rated bond.</li><li>S&amp;P currently rates the company's credit at A- but may downgrade. Moody's maintains a stable outlook.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474033\" data-linked=\"Spread widens on AbbVie bonds after Allergan bid\" data-tweet=\"$ABBV - Spread widens on AbbVie bonds after Allergan bid https://seekingalpha.com/news/3474033-spread-widens-on-abbvie-bonds-after-allergan-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3474033-spread-widens-on-abbvie-bonds-after-allergan-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474028\" data-ts=\"1561572007\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474028-ferroglobe-and-key-energy-services-among-energy-materials-gainers-ncs-multistage-and-genie\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ferroglobe and Key Energy Services among Energy/Materials gainers; NCS Multistage and Genie Energy among losers</a></h4><ul><li><b>Gainers: </b>Ferroglobe (NASDAQ:<a href='https://seekingalpha.com/symbol/GSM' title='Ferroglobe PLC'>GSM</a>) <font color=\"green\">+13%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"green\">+13%</font>. Ensco Rowan (NYSE:<a href='https://seekingalpha.com/symbol/ESV' title='Ensco Rowan plc'>ESV</a>) <font color=\"green\">+12%</font>. Nabors Industries (NYSE:<a href='https://seekingalpha.com/symbol/NBR' title='Nabors Industries Ltd.'>NBR</a>) <font color=\"green\">+9%</font>. Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited'>SDRL</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>NCS Multistage (NASDAQ:<a href='https://seekingalpha.com/symbol/NCSM' title='NCS Multistage Holdings, Inc.'>NCSM</a>) <font color=\"red\">-7%</font>. Genie Energy (NYSE:<a href='https://seekingalpha.com/symbol/GNE' title='Genie Energy Ltd.'>GNE</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474028\" data-linked=\"Ferroglobe and Key Energy Services among Energy/Materials gainers; NCS Multistage and Genie Energy among losers\" data-tweet=\"$GSM $KEG $VAL - Ferroglobe and Key Energy Services among Energy/Materials gainers; NCS Multistage and Genie Energy among losers https://seekingalpha.com/news/3474028-ferroglobe-and-key-energy-services-among-energy-materials-gainers-ncs-multistage-and-genie?source=tweet\" data-url=\"https://seekingalpha.com/news/3474028-ferroglobe-and-key-energy-services-among-energy-materials-gainers-ncs-multistage-and-genie\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474023\" data-ts=\"1561571140\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474023-bofaml-turns-bearish-after-paychex-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofAML turns bearish after Paychex earnings</a></h4><ul><li>Bank of America Merrill Lynch downgrades Paychex (NASDAQ:<a href='https://seekingalpha.com/symbol/PAYX' title='Paychex, Inc.'>PAYX</a>) from Neutral to Underperform after the <a href=\"https://seekingalpha.com/news/3473884-paychex-minus-2_7-percent-mixed-q4-fy-outlook\" target=\"_blank\">mixed earnings report</a> this morning.</li><li>Analyst Jason Kupferberg cites shares trading \"far higher\" than PAYX's peers and the \"underwhelming fundamentals.\" He prefers ADP (NASDAQ:<a href='https://seekingalpha.com/symbol/ADP' title='Automatic Data Processing, Inc.'>ADP</a>) among the payroll processors.</li><li>BofAML reiterates its $82 target.</li><li>Paychex shares are <font color=\"red\">down 4%</font> to $81.42.</li><li>PAYX has a Neutral <a href=\"https://seekingalpha.com/symbol/PAYX/ratings/quant-ratings\" target=\"_blank\">Quant rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474023\" data-linked=\"BofAML turns bearish after Paychex earnings\" data-tweet=\"$PAYX $ADP - BofAML turns bearish after Paychex earnings https://seekingalpha.com/news/3474023-bofaml-turns-bearish-after-paychex-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3474023-bofaml-turns-bearish-after-paychex-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474021\" data-ts=\"1561571107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474021-bitcoin-buzz-sends-old-favorites-back-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitcoin buzz sends old favorites back up</a></h4><ul> <li>A break <a href=\"https://seekingalpha.com/news/3474006-bitcoins-gone-parabolic\" target=\"_blank\">higher</a> in Bitcoin has the gang getting back together again.</li><li>Notable spikers off the week-long Bitcoin rally include Overstock.com (<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a> <font color='green'>+23%</font>), Longfin (<a href='https://seekingalpha.com/symbol/LFIN' title='Longfin Corp.'>OTCPK:LFIN</a> <font color='green'>+29.9%</font>), Riot Blockchain (<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='green'>+15%</font>), MGT Capital Investments (<a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a> <font color='green'>+45.1%</font>), First Bitcoin Capital Corp (<a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a> <font color='green'>+81.2%</font>),  and Bitcoin Services (<a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a> <font color='green'>+41.6%</font>).</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3474021\" data-linked=\"Bitcoin buzz sends old favorites back up\" data-tweet=\"$OSTK $LFIN $RIOT - Bitcoin buzz sends old favorites back up https://seekingalpha.com/news/3474021-bitcoin-buzz-sends-old-favorites-back-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3474021-bitcoin-buzz-sends-old-favorites-back-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474020\" data-ts=\"1561570793\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACST\" target=\"_blank\">ACST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474020-acasti-up-17-after-bullish-capre-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acasti up 17% after bullish CaPre update</a></h4><ul><li>Thinly traded nano cap Acasti Pharma (<a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma Inc.'>ACST</a> <font color=\"green\">+17.1%</font>) is up a whopping 41x surge in volume after its <a href=\"https://seekingalpha.com/pr/17556084-acasti-pharma-provides-fiscal-2019-year-end-business-update\" target=\"_blank\">business update</a> this morning that including encouraging statements on lead candidate CaPre (omega-3 phospholipid), in development for the treatment of severe hypertriglyceridemia (excessive triglycerides in the blood).</li><li>President &amp; CEO Jan D'Alvise said that its Phase 3 studies, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03398005?lead=acasti&amp;phase=2&amp;rank=1\" target=\"_blank\">TRILOGY 1</a> &amp; <a href=\"https://clinicaltrials.gov/ct2/show/NCT03361501?lead=acasti&amp;phase=2&amp;rank=2\" target=\"_blank\">TRILOGY 2</a>, remain on track and on budget. Randomization has been completed and 60% of the participants have completed treatment. Topline results from T1 should be available in December followed by topline data from T2 in January 2020.</li><li>Mr. D'Alvise is optimistic about successful outcomes from the trials, citing a longer six-month treatment period at 4 gm/day (Phase 2 studies assessed 1, 2 and 4 gm/day for only 8 - 12 weeks). Dose-related responses were observed in earlier studies.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474020\" data-linked=\"Acasti up 17% after bullish CaPre update\" data-tweet=\"$ACST - Acasti up 17% after bullish CaPre update https://seekingalpha.com/news/3474020-acasti-up-17-after-bullish-capre-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3474020-acasti-up-17-after-bullish-capre-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474014\" data-ts=\"1561568473\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474014-aerovironment-and-cemtrex-among-industrial-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AeroVironment and Cemtrex among industrial losers</a></h4><ul><li><b>Gainers: </b>None</li><li><b>Losers: </b>Cemtrex (NASDAQ:<a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a>) <font color=\"red\">-18%</font>. AeroVironment (NASDAQ:<a href='https://seekingalpha.com/symbol/AVAV' title='AeroVironment, Inc.'>AVAV</a>) <font color=\"red\">-6%</font>. Ultralife (NASDAQ:<a href='https://seekingalpha.com/symbol/ULBI' title='Ultralife Corporation'>ULBI</a>) <font color=\"red\">-5%</font>. Actuant (NYSE:<a href='https://seekingalpha.com/symbol/ATU' title='Actuant Corporation'>ATU</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474014\" data-linked=\"AeroVironment and Cemtrex among industrial losers\" data-tweet=\"$CETX $AVAV $ULBI - AeroVironment and Cemtrex among industrial losers https://seekingalpha.com/news/3474014-aerovironment-and-cemtrex-among-industrial-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474014-aerovironment-and-cemtrex-among-industrial-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474012\" data-ts=\"1561568386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474012-moneygram-international-leads-financial-gainers-mmtec-and-gwg-holdings-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MoneyGram International leads financial gainers, Mmtec and GWG Holdings among losers</a></h4><ul><li><b>Gainers:</b> MoneyGram International (NASDAQ:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) <font color=\"green\">+17%</font>. U.S. Global Investors (NASDAQ:<a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>) <font color=\"green\">+15%</font>. Broadway Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/BYFC' title='Broadway Financial Corporation'>BYFC</a>) <font color=\"green\">+8%</font>. CNFinance Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CNF' title='CNFinance Holdings Limited'>CNF</a>) <font color=\"green\">+8%</font>. Fanhua (NASDAQ:<a href='https://seekingalpha.com/symbol/FANH' title='Fanhua Inc.'>FANH</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers:</b> Oxbridge Re Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/OXBR' title='Oxbridge Re Holdings Limited'>OXBR</a>) <font color=\"red\">-13%</font>. Mmtec (NASDAQ:<a href='https://seekingalpha.com/symbol/MTC' title='Mmtec, Inc.'>MTC</a>) <font color=\"red\">-9%</font>. GWG Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/GWGH' title='GWG Holdings, Inc.'>GWGH</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474012\" data-linked=\"MoneyGram International leads financial gainers, Mmtec and GWG Holdings among losers\" data-tweet=\"$MGI $GROW $BYFC - MoneyGram International leads financial gainers, Mmtec and GWG Holdings among losers https://seekingalpha.com/news/3474012-moneygram-international-leads-financial-gainers-mmtec-and-gwg-holdings-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474012-moneygram-international-leads-financial-gainers-mmtec-and-gwg-holdings-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474010\" data-ts=\"1561568339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASND\" target=\"_blank\">ASND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474010-ascendis-down-7-after-r-and-d-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ascendis down 7% after R&amp;D update</a></h4><ul><li>Ascendis Pharma A/S (<a href='https://seekingalpha.com/symbol/ASND' title='Ascendis Pharma A/S'>ASND</a> <font color=\"red\">-6.8%</font>) is down on almost triple normal volume as its <a href=\"https://seekingalpha.com/pr/17549206-ascendis-pharma-s-announces-r-and-d-day-june-26-review-endocrinology-rare-disease-pipeline\" target=\"_blank\">R&amp;D Day</a> event in New York winds down with a Q&amp;A session.</li><li>Developing...</li><li><strong>Update</strong>: Shares are down <font color=\"red\">10%</font> approaching the close as investors appear to be reacting to additional data from the <a href=\"https://clinicaltrials.gov/ct2/show/NCT03305016?term=ascendis&amp;rank=5\" target=\"_blank\">fliGHT</a> and <a href=\"https://clinicaltrials.gov/ct2/show/NCT02781727?term=ascendis&amp;rank=4\" target=\"_blank\">heiGHT</a> studies comparing TransCon hGH to Genotropin.</li><li><a href=\"https://www.sec.gov/Archives/edgar/data/1612042/000119312519181943/d769508dex991.htm\" target=\"_blank\">Slide presentation</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3474010\" data-linked=\"Ascendis down 7% after R&amp;D update\" data-tweet=\"$ASND - Ascendis down 7% after R&amp;D update https://seekingalpha.com/news/3474010-ascendis-down-7-after-r-and-d-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3474010-ascendis-down-7-after-r-and-d-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474008\" data-ts=\"1561567854\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474008-ino-xspa-eros-and-gbt-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">INO, XSPA, EROS and GBT among midday movers</a></h4><ul><li><strong>Gainers: </strong>XpresSpa Group (NASDAQ:<a href='https://seekingalpha.com/symbol/XSPA' title='XpresSpa Group, Inc.'>XSPA</a>) <font color=\"green\">+75%</font>. Aerohive Networks (NYSE:<a href='https://seekingalpha.com/symbol/HIVE' title='Aerohive Networks, Inc.'>HIVE</a>) <font color=\"green\">+39%</font>. Wah Fu Education (NASDAQ:<a href='https://seekingalpha.com/symbol/WAFU' title='Wah Fu Education Group Limited'>WAFU</a>) <font color=\"green\">+25%</font>. Marathon Patent (NASDAQ:<a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>) <font color=\"green\">+19%</font>. Professional Diversity Network (NASDAQ:<a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network, Inc.'>IPDN</a>) <font color=\"green\">+19%</font>. Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) <font color=\"green\">+18%</font>. MoneyGram International (NASDAQ:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) <font color=\"green\">+18% </font>Inovio Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a>) <font color=\"green\">+16%</font>. U.S. Global Investors (NASDAQ:<a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>) <font color=\"green\">+16%</font>. Powerbridge Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/PBTS' title='Powerbridge Technologies Co., Ltd.'>PBTS</a>) <font color=\"green\">+15%</font>.</li><li><strong>Losers: </strong>OncoCyte (NYSEMKT:<a href='https://seekingalpha.com/symbol/OCX' title='OncoCyte Corporation'>OCX</a>) <font color=\"red\">-38%</font>. Arcus Biosciences (NYSE:<a href='https://seekingalpha.com/symbol/RCUS' title='Arcus Biosciences, Inc.'>RCUS</a>) <font color=\"red\">-22%</font>. Gemphire Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics Inc.'>GEMP</a>) <font color=\"red\">-22%</font>. Cemtrex (NASDAQ:<a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a>) <font color=\"red\">-21%</font>. Eros International (NYSE:<a href='https://seekingalpha.com/symbol/EROS' title='Eros International Plc'>EROS</a>) <font color=\"red\">-20%</font>. SSLJ.com (YGTY) <font color=\"red\">-19%</font>. Care.com (NYSE:<a href='https://seekingalpha.com/symbol/CRCM' title='Care.com, Inc.'>CRCM</a>) <font color=\"red\">-18%</font>. Oxbridge Re Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/OXBR' title='Oxbridge Re Holdings Limited'>OXBR</a>) <font color=\"red\">-14%</font>. Moxian (NASDAQ:<a href='https://seekingalpha.com/symbol/MOXC' title='Moxian, Inc.'>MOXC</a>) <font color=\"red\">-13%</font>. Global Blood Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics, Inc.'>GBT</a>) <font color=\"red\">-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474008\" data-linked=\"INO, XSPA, EROS and GBT among midday movers\" data-tweet=\"$XSPA $HIVE $WAFU - INO, XSPA, EROS and GBT among midday movers https://seekingalpha.com/news/3474008-ino-xspa-eros-and-gbt-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3474008-ino-xspa-eros-and-gbt-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474007\" data-ts=\"1561567774\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DB\" target=\"_blank\">DB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474007-deutsche-bankplus-3_7-job-cuts-pact-expected\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank +3.7% as job cuts pact expected</a></h4><ul><li>Deutsche Bank (NYSE:<a href='https://seekingalpha.com/symbol/DB' title='Deutsche Bank Aktiengesellschaft'>DB</a>)<font color=\"green\"> surges 3.7%</font> after <em>Handelsblatt</em> reports that management and labor reps are likely to<a href=\"https://www.handelsblatt.com/finanzen/banken-versicherungen/fusion-mit-postbank-deutsche-bank-einigung-ueber-arbeitsplatzabbau/24495776.html\" target=\"_blank\"> reach an agreement </a>on job cuts as a result of merging two domestic bank units.</li><li>The deal includes 700-750 jobs eliminated at the two head offices of Deutsche Bank and its second retail brand, Postbank.</li><li>1,200 more back-office jobs expected to be cut by 2022.</li><li>Sees details hashed out by mid-2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474007\" data-linked=\"Deutsche Bank +3.7% as job cuts pact expected\" data-tweet=\"$DB - Deutsche Bank +3.7% as job cuts pact expected https://seekingalpha.com/news/3474007-deutsche-bankplus-3_7-job-cuts-pact-expected?source=tweet\" data-url=\"https://seekingalpha.com/news/3474007-deutsche-bankplus-3_7-job-cuts-pact-expected\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474006\" data-ts=\"1561567451\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474006-bitcoins-gone-parabolic\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitcoin&#39;s gone parabolic</a></h4><ul><li>It was only a few days ago that Bitcoin (<a href='https://seekingalpha.com/symbol/BTC-USD' title='Bitcoin USD'>BTC-USD</a>) was facing stern resistance to push through $10K. Now, just after the noon hour Wednesday on the East Coast, it's pushed through $13K, <font color=\"green\">up 12.5% </font>today to $13,216.</li><li>The Grayscale Bitcoin Trust (<a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a> <font color=\"green\">+14%</font>).</li><li><a href=\"https://www.coindesk.com/bitcoins-price-is-up-43-in-7-days-as-bull-frenzy-grips-market\" target=\"_blank\">Coindesk notes</a> Bitcoin is <font color=\"green\">up nearly 50% </font>over the past week. It's also more than tripled in value this year.</li><li>Most of the rest of the crypto sector is in the green as well, but the gains of other sizable players like Ether (<a href='https://seekingalpha.com/symbol/ETH-USD' title='Ethereum USD'>ETH-USD</a>), Litecoin (<a href='https://seekingalpha.com/symbol/LTC-USD' title='Litecoin USD'>LTC-USD</a>), Ripple (<a href='https://seekingalpha.com/symbol/XRP-USD' title='XRP USD'>XRP-USD</a>), and Bitcoin Cash (<a href='https://seekingalpha.com/symbol/BCH-USD' title='Bitcoin Cash USD'>BCH-USD</a>) are lagging those of the Big Dog.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474006\" data-linked=\"Bitcoin&#39;s gone parabolic\" data-tweet=\"$GBTC $BTC-USD $GBTC - Bitcoin&#39;s gone parabolic https://seekingalpha.com/news/3474006-bitcoins-gone-parabolic?source=tweet\" data-url=\"https://seekingalpha.com/news/3474006-bitcoins-gone-parabolic\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>356&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474005\" data-ts=\"1561567374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCUS\" target=\"_blank\">RCUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474005-arcus-bios-business-update-fails-to-excite-investors-shares-down-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arcus Bio&#39;s business update fails to excite investors, shares down 22%</a></h4><ul><li>Thinly traded micro cap Arcus Biosciences (<a href='https://seekingalpha.com/symbol/RCUS' title='Arcus Biosciences, Inc.'>RCUS</a> <font color=\"red\">-22.1%</font>) slumps on almost 25% higher volume, albeit on turnover of only 176K shares, following its mid-year <a href=\"https://investors.arcusbio.com/investors/events-and-presentations/presentations/default.aspx\" target=\"_blank\">pipeline update</a> presented after the close yesterday.</li><li>Investors appear to have been expecting new developments or other positive news like more bullish timelines but received neither.</li><li>Preliminary Phase 1b dose-escalation data on combo therapies of lead candidate AB928 should be available in H2 or early H1 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474005\" data-linked=\"Arcus Bio&#39;s business update fails to excite investors, shares down 22%\" data-tweet=\"$RCUS - Arcus Bio&#39;s business update fails to excite investors, shares down 22% https://seekingalpha.com/news/3474005-arcus-bios-business-update-fails-to-excite-investors-shares-down-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3474005-arcus-bios-business-update-fails-to-excite-investors-shares-down-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3474004\" data-ts=\"1561567280\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3474004-boeing-in-talks-to-reimburse-airlines-after-737-max-grounding-ceo-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing in talks to reimburse airlines after 737 MAX grounding, CEO says</a></h4><ul><li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='green'>+1.5%</font>) is having \"ongoing  conversations\" with its airline customers about <a href=\"https://www.axios.com/boeing-ceo-training-initiatives-737-max-bc8b48d7-1046-45e1-a373-fccfda05c0de.html\" target=\"_blank\">possible reimbursements</a>  following the grounding of its 737 MAX, CEO Dennis Muilenburg tells Axios.</li><li>Some of the reimbursement talks included the \"financial  impact\" of the plane's grounding while others were about future  aircraft delivery and increasing services and training, the CEO says.</li><li>Muilenburg refuses to acknowledge that MCAS was a specific \"red flag\" during the  737 MAX's six-year development and certification process, saying \"there were a number of factors  involved [in the two fatal crashes], and we have to look at that holistically.\"</li><li>The 737 MAX remains on track to be cleared to return to the  skies by the end of this summer, Muilenburg says, while cautioning it could be months until the  entire worldwide fleet returns to the air.</li></ul><div class=\"tiny-share-widget\" data-id=\"3474004\" data-linked=\"Boeing in talks to reimburse airlines after 737 MAX grounding, CEO says\" data-tweet=\"$BA - Boeing in talks to reimburse airlines after 737 MAX grounding, CEO says https://seekingalpha.com/news/3474004-boeing-in-talks-to-reimburse-airlines-after-737-max-grounding-ceo-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3474004-boeing-in-talks-to-reimburse-airlines-after-737-max-grounding-ceo-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473999\" data-ts=\"1561566699\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473999-eu-set-to-ok-vodafone-liberty-global-asset-deal-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EU set to OK Vodafone/Liberty Global asset deal - Reuters</a></h4><ul>   <li>European Union regulators are set to give the go-ahead to Vodafone's (NASDAQ:<a href='https://seekingalpha.com/symbol/VOD' title='Vodafone Group Plc'>VOD</a>) $22B deal for <a href=\"https://www.reuters.com/article/us-liberty-global-m-a-vodafone-group-eu/eu-regulators-to-clear-vodafones-liberty-global-deal-sources-idUSKCN1TR2HO?il=0\" target=\"_blank\">Liberty Global's cable nets</a> in Germany and Central Europe, Reuters reports.</li>    <li>That's based on concessions that the companies had offered up in May, according to the report -- particularly getting rival Telefonica Deutschland (<a href=\"http://seekingalpha.com/symbol/TEF\" target=\"_blank\">TEF</a> <font color=\"green\">+0.7%</font>) access to the merged high-speed broadband network.</li>    <li>Vodafone is <font color=\"green\">up 1.9%</font> while Liberty Global is paring losses somewhat, with <a href='https://seekingalpha.com/symbol/LBTYA' title='Liberty Global Plc'>LBTYA</a> <font color=\"red\">down just 0.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3473999\" data-linked=\"EU set to OK Vodafone/Liberty Global asset deal - Reuters\" data-tweet=\"$VOD $LBTYA $TEF - EU set to OK Vodafone/Liberty Global asset deal - Reuters https://seekingalpha.com/news/3473999-eu-set-to-ok-vodafone-liberty-global-asset-deal-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3473999-eu-set-to-ok-vodafone-liberty-global-asset-deal-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473997\" data-ts=\"1561566540\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473997-semis-gain-on-micron-beat-trade-optimism\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semis gain on Micron beat, trade optimism</a></h4><ul><li>The Philadelphia Semiconductor Index <font color=\"green\">gains 3.6%</font> while the tech sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>) <font color=\"green\">rises 1.5%</font> after a combination of positive news for the sector.</li><li>Micron reported <a href=\"https://seekingalpha.com/news/3473723-micron-plus-4-percent-q3-earnings-strength\" target=\"_blank\">Q3 beats</a> and revealed it will further decrease its <a href=\"https://seekingalpha.com/news/3473752-micron-call-nand-wafer-cuts-double-mixed-q4-guide\" target=\"_blank\">NAND wafer starts</a> to help control the oversupply.</li><li>Earlier today, U.S. Treasury Secretary Mnuchin <a href=\"https://seekingalpha.com/news/3473966-apple-plus-2-percent-mnuchin-comments-wedbush-note\" target=\"_blank\">said</a> the U.S. and China are \"about 90% there\" towards a trade deal and sounded positive on the Trump-Xi meeting happening this weekend.</li><li>Related semiconductor ETFs: <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/PSI' title='Invesco Dynamic Semiconductors Portfolio ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3473997\" data-linked=\"Semis gain on Micron beat, trade optimism\" data-tweet=\"$XLK $SOXL $SOXX - Semis gain on Micron beat, trade optimism https://seekingalpha.com/news/3473997-semis-gain-on-micron-beat-trade-optimism?source=tweet\" data-url=\"https://seekingalpha.com/news/3473997-semis-gain-on-micron-beat-trade-optimism\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473996\" data-ts=\"1561566453\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CG\" target=\"_blank\">CG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473996-east-coasts-largest-oil-refinery-to-permanently-close-after-fire\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">East Coast&#39;s largest oil refinery to permanently close after fire</a></h4><ul><li>Philadelphia Energy Solutions will <a href=\"https://www.inquirer.com/business/philadelphia-refinery-fire-plan-to-close-20190626.html\" target=\"_blank\">permanently  shut its oil refinery</a> within the next month after <a href=\"https://seekingalpha.com/news/3472988-rbob-gasoline-surges-following-philadelphia-refinery-fire\" target=\"_blank\">last week's massive fire</a> caused  substantial damage to the complex, says Philadelphia Mayor Jim Kenney.</li><li>Spot market wholesale gasoline prices in the New York Harbor surged ~$0.053/gal on the news, and futures prices spiked ~$0.07/gal, or 3.6%.</li><li>The refinery had <a href=\"https://www.reuters.com/article/us-refinery-blast-philadelphia-exclusive/exclusive-philadelphia-energy-solutions-seeks-to-permanently-shut-oil-refinery-sources-idUSKCN1TR09E\" target=\"_blank\">struggled financially for years</a> and went through a  bankruptcy process last year to reduce debt, but cash on hand continued to fall even after it emerged from bankruptcy in August; Credit Suisse and Bardin Hill became the controlling  owners, with former primary owners Carlyle Group (<a href='https://seekingalpha.com/symbol/CG' title='The Carlyle Group L.P.'>CG</a> <font color=\"green\">+0.3%</font>) and Energy Transfer (<a href='https://seekingalpha.com/symbol/ET' title='Energy Transfer LP'>ET</a> <font color=\"green\">+1.5%</font>) subsidiary Sunoco Logistics holding minority stakes.</li><li>Refining stocks are rallying, but oil analyst Tom Kloza says east coast pump prices <a href=\"https://www.cnbc.com/2019/06/26/oil-jumps-2point5percent-in-sudden-move-to-above-59.html\" target=\"_blank\">should rise no more than $0.05/gal</a>, as the loss of supply will be made up from elsewhere, including the  Gulf Coast, Europe and Canada, since the entire world is well supplied.</li><li><a href='https://seekingalpha.com/symbol/CLMT' title='Calumet Specialty Products Partners, L.P.'>CLMT</a> <font color=\"green\">+5.2%</font>, <a href='https://seekingalpha.com/symbol/PBF' title='PBF Energy Inc.'>PBF</a> <font color=\"green\">+4.6%</font>, <a href='https://seekingalpha.com/symbol/VLO' title='Valero Energy Corporation'>VLO</a> <font color=\"green\">+3.7%</font>, <a href='https://seekingalpha.com/symbol/MPC' title='Marathon Petroleum Corporation'>MPC</a> <font color=\"green\">+3.7%</font>, <a href='https://seekingalpha.com/symbol/PSX' title='Phillips 66'>PSX</a> <font color=\"green\">+3.3%</font>, <a href='https://seekingalpha.com/symbol/CVI' title='CVR Energy, Inc.'>CVI</a> <font color=\"green\">+0.8%</font>, <a href='https://seekingalpha.com/symbol/HFC' title='HollyFrontier Corporation'>HFC</a> <font color=\"green\">+0.3%</font>.</li><li>The broader energy sector also is powering higher after the U.S. government reported a <a href=\"https://seekingalpha.com/news/3473967-oil-surges-biggest-u-s-crude-inventory-drawdown-nearly-three-years\" target=\"_blank\">multi-year high draw</a> in domestic crude stockpiles.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473996\" data-linked=\"East Coast&#39;s largest oil refinery to permanently close after fire\" data-tweet=\"$CG $ET $PBF - East Coast&#39;s largest oil refinery to permanently close after fire https://seekingalpha.com/news/3473996-east-coasts-largest-oil-refinery-to-permanently-close-after-fire?source=tweet\" data-url=\"https://seekingalpha.com/news/3473996-east-coasts-largest-oil-refinery-to-permanently-close-after-fire\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>151&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473995\" data-ts=\"1561566038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LITE\" target=\"_blank\">LITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473995-huawei-suppliers-gain-after-micron-resumes-shipments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Huawei suppliers gain after Micron resumes shipments</a></h4><ul><li>The companies move after yesterday's Micron earnings report, where the company revealed it had resumed some shipments to the Chinese firm after appearing to find a workaround to the U.S. ban.</li><li>Gainers include Lumentum (<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a> <font color='green'>+5.1%</font>), Semtech (<a href='https://seekingalpha.com/symbol/SMTC' title='Semtech Corporation'>SMTC</a> <font color='green'>+2.8%</font>), Qorvo (<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc.'>QRVO</a> <font color='green'>+4.2%</font>), and Broadcom (<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Inc.'>AVGO</a> <font color='green'>+1.7%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3473995\" data-linked=\"Huawei suppliers gain after Micron resumes shipments\" data-tweet=\"$LITE $SMTC $QRVO - Huawei suppliers gain after Micron resumes shipments https://seekingalpha.com/news/3473995-huawei-suppliers-gain-after-micron-resumes-shipments?source=tweet\" data-url=\"https://seekingalpha.com/news/3473995-huawei-suppliers-gain-after-micron-resumes-shipments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473991\" data-ts=\"1561565135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVT\" target=\"_blank\">AVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473991-avnet-names-new-cmo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avnet names new CMO</a></h4><ul><li>Avnet (NASDAQ:<a href='https://seekingalpha.com/symbol/AVT' title='Avnet, Inc.'>AVT</a>) <a href=\"https://seekingalpha.com/pr/17556638-avnet-announces-new-chief-marketing-officer\" target=\"_blank\">announces</a> the internal promotion of Jessica Daughetee to Chief Marketing Officer.</li><li>Daughetee most recently served as the VP of Global Content, Marketing, and Media.</li><li>AVT shares are <font color=\"green\">up 2.9%</font> to $44.38.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473991\" data-linked=\"Avnet names new CMO\" data-tweet=\"$AVT - Avnet names new CMO https://seekingalpha.com/news/3473991-avnet-names-new-cmo?source=tweet\" data-url=\"https://seekingalpha.com/news/3473991-avnet-names-new-cmo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473988\" data-ts=\"1561564834\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473988-unifirst-leads-consumer-gainers-vuzix-and-pyxus-international-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UniFirst leads consumer gainers; Vuzix and Pyxus International among losers</a></h4><ul><li><b>Gainers: </b>UniFirst (NYSE:<a href='https://seekingalpha.com/symbol/UNF' title='UniFirst Corporation'>UNF</a>) <font color=\"green\">+7%</font>. G-III Apparel Group (NASDAQ:<a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, Ltd.'>GIII</a>) <font color=\"green\">+6%</font>. The Alkaline Water Company (NASDAQ:<a href='https://seekingalpha.com/symbol/WTER' title='The Alkaline Water Company Inc.'>WTER</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Pyxus International (NYSE:<a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a>) <font color=\"red\">-11%</font>. Fuling Global (NASDAQ:<a href='https://seekingalpha.com/symbol/FORK' title='Fuling Global Inc.'>FORK</a>) <font color=\"red\">-8%</font>. Vuzix (NASDAQ:<a href='https://seekingalpha.com/symbol/VUZI' title='Vuzix Corporation'>VUZI</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473988\" data-linked=\"UniFirst leads consumer gainers; Vuzix and Pyxus International among losers\" data-tweet=\"$UNF $GIII $WTER - UniFirst leads consumer gainers; Vuzix and Pyxus International among losers https://seekingalpha.com/news/3473988-unifirst-leads-consumer-gainers-vuzix-and-pyxus-international-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3473988-unifirst-leads-consumer-gainers-vuzix-and-pyxus-international-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473971\" data-ts=\"1561563437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCX\" target=\"_blank\">OCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473971-oncocyte-not-quite-determavu-validation-study-shares-down-41\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OncoCyte not quite there with DetermaVu validation study; shares down 41%</a></h4><ul><li>Thinly traded micro cap OncoCyte (<a href='https://seekingalpha.com/symbol/OCX' title='OncoCyte Corporation'>OCX</a> <font color=\"red\">-40.6%</font>) slumps on more than a 6x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/17556406-oncocyte-provides-mid-year-update\" target=\"_blank\">announcement</a> that it will need additional time to complete its CLIA validation study for its lung cancer liquid biopsy test DetermaVu.</li><li>The company needs to complete the study before offering the testing service to commercial customers. It originally planned to launch the it \"mid-year.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3473971\" data-linked=\"OncoCyte not quite there with DetermaVu validation study; shares down 41%\" data-tweet=\"$OCX - OncoCyte not quite there with DetermaVu validation study; shares down 41% https://seekingalpha.com/news/3473971-oncocyte-not-quite-determavu-validation-study-shares-down-41?source=tweet\" data-url=\"https://seekingalpha.com/news/3473971-oncocyte-not-quite-determavu-validation-study-shares-down-41\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473968\" data-ts=\"1561562938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473968-unifirstplus-5_8-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UniFirst +5.8% post Q3 results</a></h4><ul><li>UniFirst\u2019s (<a href='https://seekingalpha.com/symbol/UNF' title='UniFirst Corporation'>UNF</a> <font color=\"green\">+5.8%</font>) solid selling environment and improved pricing allowed the company to deliver record <a href=\"https://seekingalpha.com/pr/17556066-unifirst-announces-financial-results-third-quarter-fiscal-2019\" target=\"_blank\">Q3</a> revenues off improved organic growth to $453.7M (+6.2% Y/Y).</li><li>Segment wise revenue: Core Laundry Operations was $399.8M (+5.5% Y/Y); Specialty Garments $37.3M (+9.6% Y/Y) &amp; First Aid of $16.6M (+16.6% Y/Y).</li><li>Segment wise operating margin: Total <font color=\"green\">increased 225 bps</font> to 13.27%; Core Laundry Operations <font color=\"green\">increased 280 bps</font> to 13.4%; Specialty Garments <font color=\"red\">declined 194 bps</font> to 14.5% &amp; First Aid also <font color=\"red\">declined 206 bps</font> to 8.4%.</li><li>Cash, equivalents and short-term investments totaled $349.4M and there was no LTD outstanding as of May 25, 2019.</li><li>The Company repurchased 99,500 common shares at an average share price of $147.47 for a total of $14.7M.</li><li><b>2019 Outlook:</b> Revenues of $1.802-1.809B; EPS of $8.75-8.85.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3473845-unifirst-eps-beats-0_77-beats-revenue\" target=\"_blank\">UniFirst EPS beats by $0.77, beats on revenue</a> (Jun. 26 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3473968\" data-linked=\"UniFirst +5.8% post Q3 results\" data-tweet=\"$UNF - UniFirst +5.8% post Q3 results https://seekingalpha.com/news/3473968-unifirstplus-5_8-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3473968-unifirstplus-5_8-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473967\" data-ts=\"1561562824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473967-oil-surges-after-biggest-u-s-crude-inventory-drawdown-in-nearly-three-years\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil surges after biggest U.S. crude inventory drawdown in nearly three years</a></h4><ul><li>U.S. crude prices extend previous gains after EIA data showed domestic stockpiles <a href=\"https://seekingalpha.com/news/3473965-crude-rises-unexpected-inventory-draw\" target=\"_blank\">plunged 12.8M barrels</a> for the week ended June 21, the <a href=\"https://www.cnbc.com/2019/06/26/oil-jumps-2point5percent-in-sudden-move-to-above-59.html\" target=\"_blank\">biggest weekly decline</a> since a 14.5M-barrel draw in September 2016; WTI <font color=\"green\">+3.5%</font> to $59.83/bbl, Brent <font color=\"green\">+2.7%</font> at $66.81/bbl.</li><li>Analyst consensus from S&amp;P Global Platts had <a href=\"https://www.marketwatch.com/story/us-oil-futures-extend-climb-as-us-weekly-crude-supplies-drop-by-nearly-13-million-barrels-2019-06-26\" target=\"_blank\">anticipated a decline of 2.8M barrels</a> in U.S. crude stocks.</li><li>Oil prices already were higher amid simmering tensions between Iran and the U.S. as well as last week's shutdown of the east coast's largest gasoline refinery, Philadelphia Energy Solutions.</li><li>The energy group has surged to the top of the S&amp;P 500 sector leaderboard: <a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color=\"green\">+1%</font>, <a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color=\"green\">+5.3%</font>, <a href='https://seekingalpha.com/symbol/HES' title='Hess Corporation'>HES</a> <font color=\"green\">+5.3%</font>, <a href='https://seekingalpha.com/symbol/NBL' title='Noble Energy, Inc.'>NBL</a> <font color=\"green\">+4.6%</font>, <a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color=\"green\">+4.4%</font>, <a href='https://seekingalpha.com/symbol/EOG' title='EOG Resources, Inc.'>EOG</a> <font color=\"green\">+4.4%</font>, <a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a> <font color=\"green\">+4.3%</font>, <a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a> <font color=\"green\">+4.1%</font>, <a href='https://seekingalpha.com/symbol/DVN' title='Devon Energy Corporation'>DVN</a> <font color=\"green\">+4%</font>, <a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color=\"green\">+3.9%</font>, <a href='https://seekingalpha.com/symbol/PXD' title='Pioneer Natural Resources Company'>PXD</a> <font color=\"green\">+2.7%</font>, <a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a> <font color=\"green\">+2.5%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3473967\" data-linked=\"Oil surges after biggest U.S. crude inventory drawdown in nearly three years\" data-tweet=\"$XOM $COP $NBL - Oil surges after biggest U.S. crude inventory drawdown in nearly three years https://seekingalpha.com/news/3473967-oil-surges-after-biggest-u-s-crude-inventory-drawdown-in-nearly-three-years?source=tweet\" data-url=\"https://seekingalpha.com/news/3473967-oil-surges-after-biggest-u-s-crude-inventory-drawdown-in-nearly-three-years\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>122&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473966\" data-ts=\"1561562634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473966-appleplus-2-after-mnuchin-comments-wedbush-note\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple +2% after Mnuchin comments, Wedbush note</a></h4><ul><li>Wedbush's Daniel Ives says this morning's positive US-China comments from U.S. Treasury Secretary Mnuchin could end up removing a major overhang for Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>).</li><li>Mnuchin said the countries are \"about 90% there\" towards a trade deal and indicated positive news could come out of the Trump-Xi meeting at this weekend's G20 summit.</li><li>Ives writes that the Street has been factoring in the worst case trade scenario for Apple with the stock currently reflecting longer-term risk of a potential $2 EPS loss.</li><li>Wedbush thinks resolved trade tensions could add $20 to $25 per share to Apple in the coming months.</li><li>The firm maintains an Outperform rating and $235 PT.</li><li>Apple shares are <font color=\"green\">up 2.2%</font> to $199.89.</li><li>Apple has a Very Bullish<a href=\"https://seekingalpha.com/symbol/AAPL/ratings/quant-ratings\" target=\"_blank\"> Quant rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473966\" data-linked=\"Apple +2% after Mnuchin comments, Wedbush note\" data-tweet=\"$AAPL - Apple +2% after Mnuchin comments, Wedbush note https://seekingalpha.com/news/3473966-appleplus-2-after-mnuchin-comments-wedbush-note?source=tweet\" data-url=\"https://seekingalpha.com/news/3473966-appleplus-2-after-mnuchin-comments-wedbush-note\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473965\" data-ts=\"1561562593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473965-crude-rises-on-unexpected-inventory-draw\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude rises on unexpected inventory draw</a></h4><ul><li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories:</a> Crude <strong>-12.8M</strong> barrels vs. -2.4M consensus, -3.1M last week.</li><li>Gasoline <strong>-1M</strong> barrels vs. +0.3M consensus, -1.7M last week.</li><li>Distillates <strong>-2.4</strong><strong>M</strong> barrels vs. +0.5M consensus, -0.6M last week.</li><li>Futures <font color=\"green\">+2.9%</font> to $59.46.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473965\" data-linked=\"Crude rises on unexpected inventory draw\" data-tweet=\"$USO $OIL $UCO - Crude rises on unexpected inventory draw https://seekingalpha.com/news/3473965-crude-rises-on-unexpected-inventory-draw?source=tweet\" data-url=\"https://seekingalpha.com/news/3473965-crude-rises-on-unexpected-inventory-draw\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473958\" data-ts=\"1561561458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473958-inovio-pharmaceuticals-and-neos-therapeutics-among-healthcare-gainers-mesoblast-and-oncocyte\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inovio Pharmaceuticals and Neos Therapeutics among healthcare gainers; Mesoblast and OncoCyte  among losers</a></h4><ul><li><b>Gainers: </b>Acasti Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma Inc.'>ACST</a>) <font color=\"green\">+23%</font>. Inovio Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a>) <font color=\"green\">+18%</font>. Genprex (NASDAQ:<a href='https://seekingalpha.com/symbol/GNPX' title='Genprex, Inc.'>GNPX</a>) <font color=\"green\">+13%</font>. Neos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NEOS' title='Neos Therapeutics, Inc.'>NEOS</a>) <font color=\"green\">+10%</font>. Genocea Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GNCA' title='Genocea Biosciences, Inc.'>GNCA</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>OncoCyte (NYSEMKT:<a href='https://seekingalpha.com/symbol/OCX' title='OncoCyte Corporation'>OCX</a>) <font color=\"red\">-35%</font>. Gemphire Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics Inc.'>GEMP</a>) <font color=\"red\">-26%</font>. Arcus Biosciences (NYSE:<a href='https://seekingalpha.com/symbol/RCUS' title='Arcus Biosciences, Inc.'>RCUS</a>) <font color=\"red\">-16%</font>. Global Blood Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics, Inc.'>GBT</a>) <font color=\"red\">-11%</font>. Mesoblast (NASDAQ:<a href='https://seekingalpha.com/symbol/MESO' title='Mesoblast Limited'>MESO</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473958\" data-linked=\"Inovio Pharmaceuticals and Neos Therapeutics among healthcare gainers; Mesoblast and OncoCyte  among losers\" data-tweet=\"$ACST $INO $GNPX - Inovio Pharmaceuticals and Neos Therapeutics among healthcare gainers; Mesoblast and OncoCyte among losers https://seekingalpha.com/news/3473958-inovio-pharmaceuticals-and-neos-therapeutics-among-healthcare-gainers-mesoblast-and-oncocyte?source=tweet\" data-url=\"https://seekingalpha.com/news/3473958-inovio-pharmaceuticals-and-neos-therapeutics-among-healthcare-gainers-mesoblast-and-oncocyte\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473957\" data-ts=\"1561561239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473957-baml-warns-on-organic-grocery-deflation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML warns on organic grocery deflation</a></h4><ul> <li>Bank of America Merrill Lynch warns that deflationary pressure continues to build in the natural and organic parts of the grocery store sector.</li> <li>The firm points to deflation in Nielsen grocery pricing data and see elevated promotional activity in produce as having an impact.</li> <li>After factoring in the organic pricing trends, the BAML analyst team lowers it price objective on Underperform-rated Sprouts Farmers Market (<a href='https://seekingalpha.com/symbol/SFM' title='Sprouts Farmers Market, Inc.'>SFM</a> <font color='green'>+0.2%</font>) to $17 from $19 and drops its PO on Buy-rated Kroger (<a href='https://seekingalpha.com/symbol/KR' title='The Kroger Co.'>KR</a> <font color='red'>-1.1%</font>) to $28 from $30.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3473957\" data-linked=\"BAML warns on organic grocery deflation\" data-tweet=\"$SFM $KR - BAML warns on organic grocery deflation https://seekingalpha.com/news/3473957-baml-warns-on-organic-grocery-deflation?source=tweet\" data-url=\"https://seekingalpha.com/news/3473957-baml-warns-on-organic-grocery-deflation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473951\" data-ts=\"1561560640\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNX\" target=\"_blank\">SNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473951-synnexplus-10-on-q2-beats-upside-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synnex +10% on Q2 beats, upside view</a></h4><ul><li>Synnex (NYSE:<a href='https://seekingalpha.com/symbol/SNX' title='SYNNEX Corporation'>SNX</a>) <font color=\"green\">gains 10.3%</font> after yesterday's <a href=\"https://seekingalpha.com/news/3473726-synnex-eps-beats-0_15-beats-revenue\" target=\"_blank\">Q2 report</a> beat revenue and earnings estimates despite a softer IT spending environment.</li><li>The upside Q3 outlook has revenue of $5.55-5.85B (consensus: $5.58B) and EPS of $2.80-2.92 (consensus: $2.79).</li><li><a href=\"https://seekingalpha.com/pr/17555495-synnex-corporation-reports-second-quarter-fiscal-2019-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473951\" data-linked=\"Synnex +10% on Q2 beats, upside view\" data-tweet=\"$SNX - Synnex +10% on Q2 beats, upside view https://seekingalpha.com/news/3473951-synnexplus-10-on-q2-beats-upside-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3473951-synnexplus-10-on-q2-beats-upside-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473947\" data-ts=\"1561560495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLV\" target=\"_blank\">XLV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473947-healthcare-stocks-under-pressure-ahead-of-dem-debate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare stocks under pressure ahead of Dem debate</a></h4><ul><li>Medical stocks are largely in the red in early trade, extending their near-term selloff ahead to tonight's first debate between Democratic presidential hopefuls in Miami. All have proposed various schemes for extending healthcare coverage and corralling drug price increases.</li><li>Selected tickers: Health Care Select Sector SPDR ETF (<a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a> <font color=\"red\">-1.2%</font>), Vanguard Health Care ETF (<a href='https://seekingalpha.com/symbol/VHT' title='Vanguard Health Care ETF'>VHT</a> <font color=\"red\">-1.3%</font>), Abbott (<a href='https://seekingalpha.com/symbol/ABT' title='Abbott Laboratories'>ABT</a> <font color=\"red\">-1.3%</font>), AstraZeneca (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca PLC'>AZN</a> <font color=\"red\">-1.3%</font>), Bristol-Myers Squibb (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"red\">-0.8%</font>), GlaxoSmithKline (<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline plc'>GSK</a> <font color=\"red\">-1%</font>), Johnson &amp; Johnson (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"red\">-2%</font>), Eli Lilly (<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color=\"red\">-2.9%</font>), Novo Nordisk (<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a> <font color=\"red\">-0.5%</font>), Novartis (<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color=\"red\">-1.2%</font>), Pfizer (<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color=\"red\">-1.5%</font>), Amgen (<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color=\"red\">-0.5%</font>), Biogen (<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color=\"red\">-1.5%</font>), Gilead Sciences (<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color=\"red\">-2%</font>), Vertex Pharmaceuticals (<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <font color=\"red\">-0.9%</font>), Nektar Therapeutics (<a href='https://seekingalpha.com/symbol/NKTR' title='Nektar Therapeutics'>NKTR</a> <font color=\"red\">-3.3%</font>), Regeneron Pharmaceuticals (<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color=\"red\">-1.9%</font>), Incyte (<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a> <font color=\"red\">-1.5%</font>), Sage Therapeutics (<a href='https://seekingalpha.com/symbol/SAGE' title='Sage Therapeutics, Inc.'>SAGE</a> <font color=\"red\">-1.2%</font>), UnitedHealth Group (<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Incorporated'>UNH</a> <font color=\"red\">-1.1%</font>), Cardinal Health (<a href='https://seekingalpha.com/symbol/CAH' title='Cardinal Health, Inc.'>CAH</a> <font color=\"red\">-0.2%</font>), McKesson (<a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a> <font color=\"red\">-1.2%</font>), AmerisourceBergen (<a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a> <font color=\"red\">-0.6%</font>), Tenet Healthcare (<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color=\"red\">-1.8%</font>), HCA (<a href='https://seekingalpha.com/symbol/HCA' title='HCA Healthcare, Inc.'>HCA</a> <font color=\"red\">-1.5%</font>), Humana (<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color=\"red\">-0.2%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3473947\" data-linked=\"Healthcare stocks under pressure ahead of Dem debate\" data-tweet=\"$XLV $VHT $ABT - Healthcare stocks under pressure ahead of Dem debate https://seekingalpha.com/news/3473947-healthcare-stocks-under-pressure-ahead-of-dem-debate?source=tweet\" data-url=\"https://seekingalpha.com/news/3473947-healthcare-stocks-under-pressure-ahead-of-dem-debate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>175&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473945\" data-ts=\"1561560154\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSTK\" target=\"_blank\">OSTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473945-overstock-com-bid-up-amid-bitcoin-rejuvenation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Overstock.com bid up amid Bitcoin rejuvenation</a></h4><ul> <li>Shares of Overstock.com (<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a> <font color='green'>+4.2%</font>) are being pulled up on a string again as Bitcoin rallies to close to 13K.</li> <li>OSTK is up almost 10% over the last week with some <a href=\"https://seekingalpha.com/news/3473001-overstock-com-plus-15-percent-ceo-hints-deal\" target=\"_blank\">M&amp;A intrigue</a> also in the mix.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3473945\" data-linked=\"Overstock.com bid up amid Bitcoin rejuvenation\" data-tweet=\"$OSTK - Overstock.com bid up amid Bitcoin rejuvenation https://seekingalpha.com/news/3473945-overstock-com-bid-up-amid-bitcoin-rejuvenation?source=tweet\" data-url=\"https://seekingalpha.com/news/3473945-overstock-com-bid-up-amid-bitcoin-rejuvenation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473944\" data-ts=\"1561560112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFO\" target=\"_blank\">INFO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473944-ihs-bull-praises-q2-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IHS bull praises Q2 report</a></h4><ul><li>BMO praises IHS Markit's (NASDAQ:<a href='https://seekingalpha.com/symbol/INFO' title='IHS Markit Ltd.'>INFO</a>) Q2 report with better-than-expected margins and expansion across all four segments.</li><li>Analyst Jeffrey Silber: \"While some may question why FY2019 guidance was not raised, we expect the stock to react favorably.\"</li><li>BMO reaffirms an Outperform rating and $63 price target.</li><li>INFO shares are <font color=\"green\">up 3%</font> to $61.10.</li><li>IHS has an Outperform <a href=\"https://seekingalpha.com/symbol/INFO/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473944\" data-linked=\"IHS bull praises Q2 report\" data-tweet=\"$INFO - IHS bull praises Q2 report https://seekingalpha.com/news/3473944-ihs-bull-praises-q2-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3473944-ihs-bull-praises-q2-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473943\" data-ts=\"1561559805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473943-barrick-gold-reiterates-acacia-offer-says-mine-plans-need-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barrick Gold reiterates Acacia offer, says mine plans need changes</a></h4><ul><li>Barrick Gold (<a href='https://seekingalpha.com/symbol/GOLD' title='Barrick Gold Corporation'>GOLD</a> <font color='red'>-1.6%</font>) is <a href=\"https://www.reuters.com/article/us-acacia-mining-m-a-barrick-gold/barrick-says-acacias-mine-plans-need-changes-idUSKCN1TR1OQ\" target=\"_blank\">sticking with its offer</a> to buy out Acacia Mining (<a href='https://seekingalpha.com/symbol/ABGLF' title='Acacia Mining plc'>OTCPK:ABGLF</a>), saying assumptions made by the smaller company about its mine plans were out of touch.</li><li>Acacia <a href=\"https://seekingalpha.com/news/3473267-barricks-takeover-proposal-gets-sharp-pushback-acacia\" target=\"_blank\">recently said</a> majority shareholder Barrick's proposal undervalued its mine plans and appeared to ignore the value of its exploration and development assets, but Barrick says Acacia did not raise any points it had not already considered.</li><li>Barrick says it remains \"firmly of the view that certain assumptions  made by Acacia in relation to its mine plans are not appropriately  risked or supportable and that adjustments should be made.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3473943\" data-linked=\"Barrick Gold reiterates Acacia offer, says mine plans need changes\" data-tweet=\"$GOLD $ABGLF $ABGLY - Barrick Gold reiterates Acacia offer, says mine plans need changes https://seekingalpha.com/news/3473943-barrick-gold-reiterates-acacia-offer-says-mine-plans-need-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/3473943-barrick-gold-reiterates-acacia-offer-says-mine-plans-need-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473935\" data-ts=\"1561558939\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UPWK\" target=\"_blank\">UPWK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473935-upworkplus-5-jefferies-turns-bullish-on-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Upwork +5% as Jefferies turns bullish on growth</a></h4><ul><li>Jefferies analyst Brent Thill upgrades Upwork (NASDAQ:<a href='https://seekingalpha.com/symbol/UPWK' title='Upwork Inc.'>UPWK</a>) from Hold to Buy with a $23 price target, citing the \"all-weather fundamentals.\"</li><li>Thill thinks the Q1 revenue growth likely marked the bottom and expects gradual acceleration. He also notes that annual comps will ease starting in Q2/Q3.</li><li>The analyst says UPWK could continue to grow gross services volumes over 20% for multiple years.</li><li>UPWK shares are <font color=\"green\">up 5.4%</font> to $15.83.</li><li>Upwork has a Buy <a href=\"https://seekingalpha.com/symbol/UPWK/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473935\" data-linked=\"Upwork +5% as Jefferies turns bullish on growth\" data-tweet=\"$UPWK - Upwork +5% as Jefferies turns bullish on growth https://seekingalpha.com/news/3473935-upworkplus-5-jefferies-turns-bullish-on-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3473935-upworkplus-5-jefferies-turns-bullish-on-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473933\" data-ts=\"1561558490\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473933-general-mills-and-peers-slump-on-u-s-snacks-sales-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">General Mills and peers slump on U.S. snacks sales drop</a></h4><ul> <li>A <a href=\"https://seekingalpha.com/news/3473811-general-mills-edges-higher-profit-beat\" target=\"_blank\">weak performance</a> by General Mills (<a href='https://seekingalpha.com/symbol/GIS' title='General Mills, Inc.'>GIS</a> <font color='red'>-8.2%</font>) in the North America snacks business is dragging on the food sector.</li> <li>J.M. Smucker (NYSE:<a href='https://seekingalpha.com/symbol/SJM' title='The J. M. Smucker Company'>SJM</a>) is <font color=\"red\">off 3.13%</font>, McCormick &amp; Company (NYSE:<a href='https://seekingalpha.com/symbol/MKC' title='McCormick & Company, Incorporated'>MKC</a>) is <font color=\"red\">down 2.55%</font>, Campbell Soup (NYSE:<a href='https://seekingalpha.com/symbol/CPB' title='Campbell Soup Company'>CPB</a>) is <font color=\"red\">2.39% lower</font>, Post Holdings (NYSE:<a href='https://seekingalpha.com/symbol/POST' title='Post Holdings, Inc.'>POST</a>) is <font color=\"red\">down 1.41%</font> and Conagra Brands (NYSE:<a href='https://seekingalpha.com/symbol/CAG' title='Conagra Brands, Inc.'>CAG</a>) is showing a <font color=\"red\">1.16% decline.</font></li> <li>Investors may be taking a defensive position with Conagra and McCormick both due to report earnings of their own tomorrow.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3473933\" data-linked=\"General Mills and peers slump on U.S. snacks sales drop\" data-tweet=\"$GIS $SJM $MKC - General Mills and peers slump on U.S. snacks sales drop https://seekingalpha.com/news/3473933-general-mills-and-peers-slump-on-u-s-snacks-sales-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/3473933-general-mills-and-peers-slump-on-u-s-snacks-sales-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473928\" data-ts=\"1561558235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MWA\" target=\"_blank\">MWA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473928-mueller-waterminus-9-on-goldman-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mueller Water -9% on Goldman downgrade</a></h4><ul><li>Seeing near-to-medium term downside risk to consensus estimates given his expectation for weaker incremental margins, Goldman Sachs analyst Brian Lee <a href=\"https://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Downgrades+Mueller+Water+Products+%28MWA%29+to+Sell/15646482.html\" target=\"_blank\">downgraded</a> Mueller Water Products (NYSE:<a href='https://seekingalpha.com/symbol/MWA' title='Mueller Water Products, Inc.'>MWA</a>) to Sell from Neutral.</li><li>He also cut his price target to $8 (from $10), triggering shares to <font color=\"red\">fall nearly 9%</font> in early trade, saying the company has industry-leading exposure to the housing end market, which is likely to be an ongoing headwind.</li><li>While most of the <a href=\"https://seekingalpha.com/symbol/MWA/ratings/sell-side-ratings\" target=\"_blank\">Sell Side has an Outperform rating</a> on the stock, <a href=\"https://seekingalpha.com/symbol/MWA/ratings/author-ratings#filter=all\" target=\"_blank\">SA Author's</a> and <a href=\"https://seekingalpha.com/symbol/MWA/ratings/quant-ratings\" target=\"_blank\">Quant's Bearish rating</a> is more in line with Goldman.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473928\" data-linked=\"Mueller Water -9% on Goldman downgrade\" data-tweet=\"$MWA - Mueller Water -9% on Goldman downgrade https://seekingalpha.com/news/3473928-mueller-waterminus-9-on-goldman-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3473928-mueller-waterminus-9-on-goldman-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473926\" data-ts=\"1561558102\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473926-iqiyi-china-unicom-team-on-5g-r-and-d-center\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IQiyi, China Unicom team on 5G R&amp;D center</a></h4><ul>   <li>IQiyi (<a href=\"http://seekingalpha.com/symbol/IQ\" target=\"_blank\">IQ</a> <font color=\"green\">+2%</font>) and state-owned wireless firm China Unicom (<a href=\"http://seekingalpha.com/symbol/CHU\" target=\"_blank\">CHU</a> <font color=\"green\">+0.4%</font>) are teaming up to build a joint <a href=\"https://seekingalpha.com/pr/17555817-iqiyi-establishes-strategic-partnership-china-unicom-build-joint-r-and-d-center-5g-terminal\" target=\"_blank\">research and development center</a> to apply 5G to terminal devices.</li>    <li>That will cover teamwork on aspects including 5G network slicing, 5G Multi-Access Edge Computing, big data, MR/AR/VR, and 4K/8K ultra-high-definition video.</li>    <li>China Unicom will contribute resources including 5G testing grounds along with research equipment and devices, while iQiyi will offer mixed and augmented reality VR testing spaces along with equipment and devices.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3473926\" data-linked=\"IQiyi, China Unicom team on 5G R&amp;D center\" data-tweet=\"$IQ $CHU - IQiyi, China Unicom team on 5G R&amp;D center https://seekingalpha.com/news/3473926-iqiyi-china-unicom-team-on-5g-r-and-d-center?source=tweet\" data-url=\"https://seekingalpha.com/news/3473926-iqiyi-china-unicom-team-on-5g-r-and-d-center\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473924\" data-ts=\"1561557501\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZS\" target=\"_blank\">ZS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473924-zscalerplus-1_5-bull-sings-praises\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zscaler +1.5% as bull sings praises</a></h4><ul><li>Needham reaffirms its Strong Buy rating and $89 price target for Zscaler (NASDAQ:<a href='https://seekingalpha.com/symbol/ZS' title='Zscaler, Inc.'>ZS</a>).</li><li>Analyst Alex Henderson thinks ZS can continue its streak of \"solid beat and raise results\" thanks to strength in customer retention, new customer adds, and margin leverage.</li><li>Henderson calls Zscaler the \"single best idea in our Security coverage\" with no meaningful competition, unique capabilities, and a funnel that's filling faster than ZS can close deals.</li><li>Zscaler shares are <font color=\"green\">up 1.5%</font> to $74.89.</li><li>ZS has an Outperform <a href=\"https://seekingalpha.com/symbol/ZS/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473924\" data-linked=\"Zscaler +1.5% as bull sings praises\" data-tweet=\"$ZS - Zscaler +1.5% as bull sings praises https://seekingalpha.com/news/3473924-zscalerplus-1_5-bull-sings-praises?source=tweet\" data-url=\"https://seekingalpha.com/news/3473924-zscalerplus-1_5-bull-sings-praises\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473914\" data-ts=\"1561556902\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCX\" target=\"_blank\">TCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473914-tucowsminus-6_6-amid-new-short-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tucows -6.6% amid new short report</a></h4><ul>   <li>Tucows (NASDAQ:<a href='https://seekingalpha.com/symbol/TCX' title='Tucows Inc.'>TCX</a>) is sliding out of today's open, <font color=\"red\">down 6.6%</font>, after Kerrisdale Capital has issued a new short report calling it \"<a href=\"https://seekingalpha.com/article/4272182-tucows-three-terrible-businesses-one\" target=\"_blank\">three terrible businesses in one</a>.\"</li>    <li>The stock's worth about half what its current price is, Kerrisdale says, and the company is redeploying cash into an \"ill-fated\" fiber network experiment while operating two declining legacy tech/telecom businesses.</li>    <li>Kerrisdale expects the company will miss on top and bottom lines in 2019 and that those shortfalls will widen in 2020 and 2021.</li>    <li>Short interest on Tucows is running about 17% of its float.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3473914\" data-linked=\"Tucows -6.6% amid new short report\" data-tweet=\"$TCX - Tucows -6.6% amid new short report https://seekingalpha.com/news/3473914-tucowsminus-6_6-amid-new-short-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3473914-tucowsminus-6_6-amid-new-short-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473908\" data-ts=\"1561556539\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473908-broadcom-components-deals-getting-hard-look-from-eu\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broadcom components deals getting hard look from EU</a></h4><ul>   <li>Broadcom (<a href=\"http://seekingalpha.com/symbol/AVGO\" target=\"_blank\">AVGO</a> <font color=\"green\">+1.9%</font>) is facing a European Union investigation into sales tactics for its <a href=\"https://ca.news.yahoo.com/eu-antitrust-regulators-investigate-broadcom-095510512.html\" target=\"_blank\">components for modems and TV set-top boxes</a>, and the EU is taking the step of pressing to force Broadcom to stop potentially illegal behavior before the probe's done.</li>    <li>Those are the first interim measures in 18 years, and the EU says it's taking that step because it believes Broadcom conduct could result in eliminating competition before it can wrap its examination.</li>    <li>Exclusivity clauses in Broadcom's contracts have resulted in seven major customers buying chips only from Broadcom.</li>    <li>The European Commission can levy fines of up to 10% of a company's global revenues.</li>    <li>Broadcom has two weeks to respond to the EU, and can request a closed-door hearing on the matter. It says so far the concerns are \"without merit\" and it's complying with EC rules.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3473908\" data-linked=\"Broadcom components deals getting hard look from EU\" data-tweet=\"$AVGO - Broadcom components deals getting hard look from EU https://seekingalpha.com/news/3473908-broadcom-components-deals-getting-hard-look-from-eu?source=tweet\" data-url=\"https://seekingalpha.com/news/3473908-broadcom-components-deals-getting-hard-look-from-eu\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473900\" data-ts=\"1561555676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTNP\" target=\"_blank\">TTNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473900-titan-pharma-up-16-premarket-on-european-nod-for-buprenorphine-implant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Titan Pharma up 16% premarket on European nod for buprenorphine implant</a></h4><ul><li>Thinly traded nano cap Titan Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a>) is up <font color=\"green\">16%</font> premarket in reaction to European Commission <a href=\"https://seekingalpha.com/pr/17556418-titan-pharmaceuticals-molteni-receive-european-regulatory-approval-probuphine\" target=\"_blank\">approval</a> of Sixmo-buprenorphine implant for the substitution treatment of opioid dependence in clinically stable adult patients who require no more than 8 mg/day of sublingual buprenorphine as part of overall medical, social and psychological treatment.</li><li>Italian firm Molteni &amp; C. dei F.lli Alitti Società di Esercizio S.p.A. owns commercialization rights in Europe, certain Commonwealth of Independent States, the Middle East and North Africa.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473900\" data-linked=\"Titan Pharma up 16% premarket on European nod for buprenorphine implant\" data-tweet=\"$TTNP - Titan Pharma up 16% premarket on European nod for buprenorphine implant https://seekingalpha.com/news/3473900-titan-pharma-up-16-premarket-on-european-nod-for-buprenorphine-implant?source=tweet\" data-url=\"https://seekingalpha.com/news/3473900-titan-pharma-up-16-premarket-on-european-nod-for-buprenorphine-implant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473895\" data-ts=\"1561555337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGT\" target=\"_blank\">TGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473895-targetplus-1_3-after-unveiling-two-day-deals-event\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Target +1.3% after unveiling two-day deals event</a></h4><ul><li>Target (NYSE:<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a>) is taking dead aim at Amazon Prime Day with its Target Deal Days event overlapping on July 15-16.</li><li>The retailer says deals on top national and only-at-Target brands will be offered across categories like home and apparel. Target also reminds that no membership is required.</li><li>Last year, Target generated one of its biggest online sales days of the year with a one-day sale that competed directly with Amazon Prime Day.</li><li>In general, retail analysts see Amazon, Target and Walmart increasing market share during the July shopping event at the expense of smaller chains.</li> <li>TGT  <font color=\"green\">+1.26%</font> premarket to  $86.78.</li>  <li>Source: <a href=\"https://seekingalpha.com/pr/17555592-target-debut-target-deal-days-membership-required\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3473895\" data-linked=\"Target +1.3% after unveiling two-day deals event\" data-tweet=\"$TGT - Target +1.3% after unveiling two-day deals event https://seekingalpha.com/news/3473895-targetplus-1_3-after-unveiling-two-day-deals-event?source=tweet\" data-url=\"https://seekingalpha.com/news/3473895-targetplus-1_3-after-unveiling-two-day-deals-event\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473894\" data-ts=\"1561555336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INO\" target=\"_blank\">INO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473894-inovio-completes-enrollment-in-late-stage-of-vgxminus-3100-in-hpv-shares-up-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inovio completes enrollment in late-stage of VGX-3100 in HPV; shares up 5% premarket</a></h4><ul> <li>Inovio Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a>) has <a href=\"https://seekingalpha.com/pr/17556419-inovio-completes-enrollment-vgxminus-3100-phase-3-trial-reveal-1-treatment-hpv-related\" target=\"_blank\">completed</a> target enrollment of 198 participants for its Phase 3 registration trial (\"REVEAL 1\") of VGX-3100, a DNA-based immunotherapy being tested to treat cervical dysplasia caused by human papillomavirus &#40;HPV&#41;.</li>  <li>A confirmatory Phase 3 trial (REVEAL 2) is currently enrolling with FDA submission expected in 2021.</li> <li>The primary endpoint of the Phase 3 study is regression of cervical HSIL and virologic clearance of HPV 16 and/or HPV 18 in the cervix.</li><li>The studies will evaluate cervical tissue changes at approx. 9 months after beginning a three dose regimen administered at months 0, 1, and 3.</li><li>Shares are up <font color=\"green\">5%</font> premarket.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3473894\" data-linked=\"Inovio completes enrollment in late-stage of VGX-3100 in HPV; shares up 5% premarket\" data-tweet=\"$INO - Inovio completes enrollment in late-stage of VGX-3100 in HPV; shares up 5% premarket https://seekingalpha.com/news/3473894-inovio-completes-enrollment-in-late-stage-of-vgxminus-3100-in-hpv-shares-up-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3473894-inovio-completes-enrollment-in-late-stage-of-vgxminus-3100-in-hpv-shares-up-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}